CHTH 10-Q Quarterly Report March 31, 2015 | Alphaminr
CNL Healthcare Properties, Inc.

CHTH 10-Q Quarter ended March 31, 2015

CNL HEALTHCARE PROPERTIES, INC.
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
10-Q 1 d902155d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-54685

CNL Healthcare Properties, Inc.

(Exact name of registrant as specified in its charter)

Maryland 27-2876363

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

CNL Center at City Commons
450 South Orange Avenue
Orlando, Florida
32801
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (407) 650-1000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer x (Do not check if a smaller reporting company) Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ¨ No x

The number of shares of common stock of the registrant outstanding as of May 4, 2015 was 141,164,264.


CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

INDEX

Page

PART I. FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Information (unaudited):

Condensed Consolidated Balance Sheets

2

Condensed Consolidated Statements of Operations

3

Condensed Consolidated Statements of Comprehensive Loss

4

Condensed Consolidated Statements of Stockholders’ Equity and Redeemable Noncontrolling Interest

5

Condensed Consolidated Statements of Cash Flows

6

Notes to Condensed Consolidated Financial Statements

7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

31

Item 3. Quantitative and Qualitative Disclosures about Market Risk

53

Item 4. Controls and Procedures

54

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

54

Item 1A. Risk Factors

54

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

54

Item 3. Defaults Upon Senior Securities

57

Item 4. Mine Safety Disclosures

57

Item 5. Other Information

57

Item 6. Exhibits

57

Signatures

59

Exhibits

60


Item 1. Financial Statements

CNL HEALTHCARE PROERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(in thousands, except per share data)

March 31,
2015
December 31,
2014

ASSETS

Real estate assets:

Real estate investment properties, net (including VIEs $173,192 and $174,449, respectively)

$ 1,712,979 $ 1,657,500

Real estate under development, including land (including VIEs $66,013 and $47,153, respectively)

66,013 47,153

Total real estate assets, net

1,778,992 1,704,653

Intangibles, net (including VIEs $24,673 and $25,519, respectively)

130,555 140,264

Cash (including VIEs $3,911 and $6,280, respectively)

116,365 91,355

Other assets (including VIEs $1,974 and $511, respectively)

22,150 19,738

Loan costs, net (including VIEs $2,243 and $2,300, respectively)

13,096 14,012

Deferred rent and lease incentives (including VIEs $3,296 and $2,978, respectively)

9,321 8,240

Restricted cash (including VIEs $2,594 and $5,304, respectively)

7,779 10,753

Total assets

$ 2,078,258 $ 1,989,015

LIABILITIES AND EQUITY

Liabilities:

Mortgages and other notes payable, net (including VIEs $146,298 and $137,754, respectively)

$ 837,847 $ 853,561

Credit facilities

175,000 206,403

Accounts payable and accrued expenses (including VIEs $11,725 and $10,487, respectively)

33,431 29,443

Other liabilities (including VIEs $5,756 and $4,949, respectively)

28,387 27,448

Total liabilities

1,074,665 1,116,855

Commitments and contingencies (Note 14)

Redeemable noncontrolling interest

568 568

Stockholders’ equity:

Preferred stock, $0.01 par value per share, 200,000 shares authorized; none issued or outstanding

Excess shares, $0.01 par value per share, 300,000 shares authorized; none issued or outstanding

Common stock, $0.01 par value per share, 1,120,000 shares authorized, 135,511 and 116,672 shares issued, and 134,892 and 116,256 shares outstanding, respectively

1,349 1,163

Capital in excess of par value

1,175,026 1,007,326

Accumulated loss

(101,091 ) (83,091 )

Accumulated distributions

(62,590 ) (49,342 )

Accumulated other comprehensive loss

(10,064 ) (4,864 )

Total stockholders’ equity

1,002,630 871,192

Noncontrolling interest

395 400

Total equity

1,003,593 872,160

Total liabilities and equity

$ 2,078,258 $ 1,989,015

The abbreviation VIEs above means variable interest entities.

See accompanying notes to condensed consolidated financial statements

2


CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(in thousands, except per share data)

Three Months Ended
March 31,
2015 2014

Revenues:

Rental income from operating leases

$ 21,640 $ 9,722

Resident fees and services

40,032 21,956

Tenant reimbursement income

3,361 1,451

Interest income on note receivable from related party

146

Total revenues

65,033 33,275

Expenses:

Property operating expenses

32,312 16,420

General and administrative

2,019 1,757

Acquisition fees and expenses

2,330 7,205

Asset management fees

4,210 1,770

Property management fees

3,254 1,636

Impairment provision

5,524

Depreciation and amortization

23,293 11,862

Total expenses

72,942 40,650

Operating loss

(7,909 ) (7,375 )

Other income (expense):

Interest and other income

60 8

Interest expense and loan cost amortization

(9,866 ) (5,535 )

Equity in earnings (loss) of unconsolidated entities

(226 ) 349

Total other expense

(10,032 ) (5,178 )

Loss before income taxes

(17,941 ) (12,553 )

Income tax (expense) benefit

(64 ) 30

Net loss

$ (18,005 ) $ (12,523 )

Less: Net loss attributable to noncontrolling interest

(5 )

Net loss attributable to common stockholders

(18,000 ) (12,523 )

Net loss per share of common stock (basic and diluted)

$ (0.14 ) $ (0.19 )

Weighted average number of shares of common stock outstanding (basic and diluted)

129,627 65,273

See accompanying notes to condensed consolidated financial statements.

3


CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

(in thousands)

Three Months Ended
March 31,
2015 2014

Net loss

$ (18,000 ) $ (12,523 )

Other comprehensive loss:

Unrealized loss on derivative financial instruments, net

(5,268 ) (223 )

Reclassification of cash flow hedges upon derecognition

74

Unrealized loss on derivative financial instruments of equity method investments

(6 ) (26 )

Total other comprehensive income loss

(5,200 ) (249 )

Comprehensive loss

$ (23,200 ) $ (12,772 )

Less: Comprehensive loss attributable to noncontrolling interest

Comprehensive loss attributable to common stockholders

$ (23,200 ) $ (12,772 )

See accompanying notes to condensed consolidated financial statements.

4


CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY AND REDEEMABLE NONCONTROLLING INTEREST

Three Months Ended March 31, 2015 (Unaudited) and the Year Ended December 31, 2014

(in thousands, except per share data)

Redeemable Common Stock Capital in Accumulated
Other
Total Non-
Noncontrolling
Interest
Number
of Shares
Par
Value
Excess of
Par Value
Accumulated
Loss
Accumulated
Distributions
Comprehensive
Loss
Stockholders’
Equity
controlling
Interest
Total Equity

Balance at December 31, 2013

$ 58,218 $ 582 $ 500,361 $ (30,580 ) $ (17,423 ) $ (959 ) $ 451,981 451,981

Subscriptions received for common stock through public offering and reinvestment plan

56,006 560 571,764 572,324 572,324

Stock distributions

2,356 24 (24 )

Redemptions of common stock

(324 ) (3 ) (2,993 ) (2,996 ) (2,996 )

Stock issuance and offering costs

(59,782 ) (59,782 ) (59,782 )

Net loss

(52,511 ) (52,511 ) (52,511 )

Other comprehensive loss

(3,905 ) (3,905 ) (3,905 )

Distribution to holder of promoted interest

(2,000 ) (2,000 ) (2,000 )

Cash distributions declared and paid or reinvested ($0.4071 per share)

(31,919 ) (31,919 ) (31,919 )

Contribution from noncontrolling interests

568 400 968

Balance at December 31, 2014

568 116,256 1,163 1,007,326 (83,091 ) (49,342 ) (4,864 ) 871,192 400 872,160

Subscriptions received for common stock through public offering and reinvestment plan

17,897 179 188,207 188,386 188,386

Stock distributions

943 9 (9 )

Redemptions of common stock

(204 ) (2 ) (1,940 ) (1,942 ) (1,942 )

Stock issuance and offering costs

(18,558 ) (18,558 ) (18,558 )

Net loss

(18,000 ) (18,000 ) (5 ) (18,005 )

Other comprehensive loss

(5,200 ) (5,200 ) (5,200 )

Cash distributions declared and paid or reinvested ($0.1059 per share)

(13,248 ) (13,248 ) (13,248 )

Balance at March 31, 2015

$ 568 134,892 $ 1,349 $ 1,175,026 $ (101,091 ) $ (62,590 ) $ (10,064 ) $ 1,002,630 $ 395 $ 1,003,593

See accompanying notes to condensed consolidated financial statements.

5


CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)

Three Months Ended
March 31,
2015 2014

Operating activities:

Net cash flows provided by operating activities

$ 11,317 $ 6,277

Investing activities:

Acquisition of properties

(76,060 ) (186,813 )

Development of properties

(17,567 ) (12,157 )

Issuance of note receivable to related party

(1,567 )

Changes in restricted cash

2,974 (452 )

Capital expenditures

(1,785 ) (412 )

Payment of leasing costs

(418 ) (283 )

Deposits on real estate

(750 ) (2,000 )

Net cash used in investing activities

(93,606 ) (203,684 )

Financing activities:

Subscriptions received for common stock through public offering

180,738 86,839

Payment of stock issuance and offering costs

(19,388 ) (8,249 )

Distributions to stockholders, net of distribution reinvestments

(5,600 ) (2,798 )

Distribution to holder of promoted interest

(2,000 )

Redemptions of common stock

(872 ) (145 )

Draws under revolving credit facility

53,495

Repayment on revolving credit facility

(31,403 )

Proceeds from mortgage and other notes payable

18,187 69,706

Principal payments on mortgage and other notes payable

(33,936 ) (1,870 )

Lender deposits

(50 )

Payment of loan costs

(427 ) (1,104 )

Net cash flows provided by financing activities

107,299 193,824

Net increase (decrease) in cash

25,010 (3,583 )

Cash at beginning of period

91,355 44,209

Cash at end of period

$ 116,365 $ 40,626

Supplemental disclosure of non-cash investing and financing activities:

Amounts incurred but not paid (including amounts due to related parties):

Stock issuance and offering costs

$ 826 $ 1,923

Loan costs

$ 133 $ 583

Accrued development costs

$ 9,181 $ 3,149

Redemptions payable

$ 1,942 $ 235

Contingent purchase price consideration

$ $ 2,570

Unrealized loss on derivative financial instruments, net

$ 10,064 $ 1,208

See accompanying notes to condensed consolidated financial statements.

6


CNL HEALTHCARE PROPERTIES, INC, AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED MARCH 31, 2015 (UNAUDITED)

1. Organization

CNL Healthcare Properties, Inc. (“Company”) is a Maryland corporation incorporated on June 8, 2010 that elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes beginning with the year ended December 31, 2012. The Company is externally advised by CNL Healthcare Corp. (“Advisor”) and its property manager is CNL Healthcare Manager Corp. (“Property Manager”), each of which is a Florida corporation and a wholly owned subsidiary of CNL Financial Group, LLC (“Sponsor”). The Sponsor is an affiliate of CNL Financial Group, Inc. (“CNL”) and CNL Securities Corp., the managing dealer of the Offerings and a wholly-owned subsidiary of CNL (“Managing Dealer”). The Advisor is responsible for managing the Company’s affairs on a day-to-day basis and for identifying and making acquisitions and investments on behalf of the Company pursuant to an advisory agreement among the Company, the operating partnership and the Advisor. Substantially all of the Company’s acquisition, operating, administrative and certain property management services are provided by affiliates of the Advisor and the Property Manager. In addition, third-party sub-property managers have been engaged to provide certain property management services.

The Company conducts substantially all of its operations either directly or indirectly through: (1) an operating partnership, CHP Partners, LP, in which the Company is the sole limited partner and its wholly-owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly-owned TRS, CHP TRS Holding, Inc.; (3) property owner subsidiaries and lender subsidiaries, which are single purpose entities; and (4) investments in joint ventures.

On June 27, 2011, the Company commenced its initial public offering (“Initial Offering”), including shares being offered through its distribution reinvestment plan (“Reinvestment Plan”), pursuant to a registration statement on Form S-11 under the Securities Act of 1933 with the Securities Exchange Commission (“SEC”). In addition, the Company filed a follow-on registration statement on Form S-11 under the Securities Act of 1933 with the SEC in connection with the proposed offering of up to $1 billion in shares of common stock (“Follow-On Offering”), which was declared effective on February 2, 2015. Accordingly, the Company closed its Initial Offering and commenced its Follow-On Offering (collectively, the “Offerings”). The Company expects to sell shares of its common stock in the Follow-On Offering until the earlier of the date on which the maximum offering amount has been sold, or December 31, 2015; provided, however, that the Company will periodically evaluate the status of the Follow-On Offering, and its board of directors may decide to either extend the Follow-On Offering beyond December 31, 2015 or terminate the Follow-On Offering prior thereto.

The Company’s investment focus is on acquiring a diversified portfolio of healthcare real estate or real estate-related assets, primarily in the United States, within the senior housing, medical office, post-acute care and acute care asset classes. The types of senior housing that the Company may acquire include active adult communities (age-restricted and age-targeted housing), independent and assisted living facilities, continuing care retirement communities, and memory care facilities. The types of medical offices that the Company may acquire include medical office buildings, specialty medical and diagnostic service facilities, surgery centers, outpatient rehabilitation facilities, and other facilities designed for clinical services. The types of post-acute care facilities that the Company may acquire include skilled nursing facilities, long-term acute care hospitals and inpatient rehabilitative hospitals. The types of acute care facilities that the Company may acquire include general acute care hospitals and specialty surgical hospitals. The Company views, manages and evaluates its portfolio homogeneously as one collection of healthcare assets with a common goal of maximizing revenues and property income regardless of the asset class or asset type.

The Company is committed to investing the proceeds of its Offerings through strategic investment types aimed to maximize stockholder value by generating sustainable cash flow growth and increasing the value of its healthcare assets. The Company expects to primarily lease its senior housing properties to wholly-owned taxable REIT subsidiaries (“TRS”) entities and engage independent third-party managers under management agreements to operate the properties under REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”) structures; however, the Company may also lease its properties to third-party tenants under triple-net or similar lease structures, where the tenant bears all or substantially all of the costs (including cost increases, for real estate taxes, utilities, insurance and ordinary repairs). Medical office, post-acute care and acute care properties will be leased on a triple-net, net or modified gross basis to third-party tenants. In addition, the Company expects most investments will be wholly-owned, although, it has and may continue to invest through partnerships with other entities where it is believed to be appropriate and beneficial.

7


1. Organization (continued)

The Company has and may continue to invest in new property developments or properties which have not reached full stabilization. Finally, the Company also may invest in and originate mortgage, bridge or mezzanine loans or in entities that make investments similar to the foregoing investment types. The Company generally makes loans to the owners of properties to enable them to acquire land, buildings, or to develop property. In exchange, the owner generally grants the Company a first lien or collateralized interest in a participating mortgage collateralized by the property or by interests in the entity that owns the property.

2. Summary of Significant Accounting Policies

Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by generally accepted accounting principles in the United States (“GAAP”). The unaudited condensed consolidated financial statements reflect all normal recurring adjustments, which, in the opinion of management, are necessary for the fair statement of the Company’s results for the interim period presented. Operating results for the three months ended March 31, 2015 may not be indicative of the results that may be expected for the year ending December 31, 2015. Amounts as of December 31, 2014 included in the unaudited condensed consolidated financial statements have been derived from audited consolidated financial statements as of that date but do not include all disclosures required by GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

The accompanying unaudited condensed consolidated financial statements include the Company’s accounts and the accounts of its wholly owned subsidiaries or subsidiaries for which the Company has a controlling financial interest, including the accounts of variable interest entities (“VIEs”) in which the Company is the primary beneficiary. All material intercompany accounts and transactions have been eliminated in consolidation.

In accordance with the guidance for the consolidation of VIEs, the Company analyzes its variable interests, including loans, leases, guarantees, and equity investments, to determine if the entity in which it has a variable interest is a variable interest entity (“VIE”). The Company’s analysis includes both quantitative and qualitative reviews. The Company bases its quantitative analysis on the forecasted cash flows of the entity, and its qualitative analysis on its review of the design of the entity, its organizational structure including decision-making ability and financial agreements. The Company also uses its quantitative and qualitative analyses to determine if it is the primary beneficiary of the VIE, and if such determination is made, it includes the accounts of the VIE in its consolidated financial statements.

Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the allocation of purchase price, the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted stock shares issued. Accordingly, actual results could differ from those estimates.

8


2. Summary of Significant Accounting Policies (continued)

Adopted Accounting Pronouncements In April 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” This update changes the criteria for reporting discontinued operations where only disposals representing a strategic shift that has (or will have) a major effect on an entity’s operations and financial results, such as a major line of business or geographical area, should be presented as a discontinued operation. This ASU is effective prospectively for all disposals (or classifications as held for sale) of components of an entity that occur within annual periods beginning on or after December 15, 2014 with early adoption permitted. The Company has determined that the amendments will impact the Company’s determinations of which future property disposals, if any, qualify as discontinued operations and will require additional disclosure about discontinued operations for future property disposals, if any.

Recent Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers,” as a new Accounting Standard Concept (“ASC”) topic (Topic 606). The core principle of this amendment is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard further provides guidance for any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards (for example, lease contracts). This ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period, with earlier adoption not permitted. ASU 2014-09 can be adopted using one of two retrospective application methods: 1) retrospectively to each prior reporting period presented or 2) as a cumulative-effect adjustment as of the date of adoption. The Company is currently evaluating the amendments of ASU 2014-09; however, these amendments could potentially have a significant effect on the Company’s consolidated financial position, results of operations or cash flows.

In February 2015, the FASB issued ASU 2015-02, “Amendments to the Consolidation Analysis,” which requires amendments to both the variable interest entity and voting models. The amendments (i) modify the identification of variable interests (fees paid to a decision maker or service provider), the VIE characteristics for a limited partnership or similar entity and primary beneficiary determination under the VIE model, and (ii) eliminate the presumption within the current voting model that a general partner controls a limited partnership or similar entity. The new guidance is effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2015 with early adoption permitted. The amendments may be applied using either a modified retrospective or full retrospective approach. The Company is currently evaluating the effect the guidance will have on its consolidated financial position, results of operations or cash flows.

In April 2015, the FASB issued ASU 2015-03, “Simplifying the Presentation of Debt Issuance Costs,” which requires that loan costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts or premiums. The new guidance is effective for annual reporting periods, and interim periods within those annual periods, beginning after December 15, 2015 with early adoption permitted. The ASU is to be applied on retrospectively for each period presented. Upon adoption, an entity is required to comply with the applicable disclosures for a change in an accounting principle. The Company has determined that it will not early adopt this ASU and that the amendments will materially impact the Company’s consolidated financial position but will not have a material impact on the Company’s consolidated results of operations or cash flows.

9


3. Acquisitions

Real Estate Investment Properties — During the three months ended March 31, 2015, the Company acquired the following three properties, which were comprised of two medical office buildings (“MOB”) and one senior housing community:

Name and Location

Structure Date
Acquired
Purchase Price
(in thousands)

Medical Office

Novi Orthopaedic Center

Modified Lease 2/13/2015 $ 30,500 (1)

Novi, MI

Southeast Medical Office Properties

UT Cancer Institute

Modified Lease 2/20/2015 33,660

Knoxville, TN

Senior Housing

Fieldstone Memory Care (2)

Managed 3/31/2015 12,400 (1)

Yakima, WA

$ 76,560

FOOTNOTES:

(1) This represents a single property acquisition that is not considered material to the Company and as such no pro forma financial information has been included related to this property.
(2) This property was purchased from a related party of the Company’s Sponsor; refer to Note 11. “Related Party Arrangements” for additional information.

10


3. Acquisitions (continued)

During the three months ended March 31, 2014, the Company acquired the following ten properties, which were comprised of nine senior housing communities and one MOB:

Name and Location

Structure Date
Acquired
Purchase Price
(in thousands)

Medical Office

Chula Vista Medical Arts

Modified Lease 1/21/2014 $ 17,863 (1)

Chula Vista, CA (“San Diego”)

Senior Housing

Pacific Northwest II Communities

Prestige Senior Living Auburn Meadows

Managed 2/3/2014 21,930

Auburn, WA (“Seattle”)

Prestige Senior Living Bridgewood

Managed 2/3/2014 22,096

Vancouver, WA (“Portland”)

Prestige Senior Living Monticello Park

Managed 2/3/2014 27,360

Longview, WA

Prestige Senior Living Rosemont

Managed 2/3/2014 16,877

Yelm, WA

Prestige Senior Living West Hills

Managed 3/3/2014 14,986

Corvallis, OR

South Bay II Communities

Isle at Cedar Ridge

Managed 2/28/2014 21,000 (2)

Cedar Park, TX (“Austin”)

HarborChase of Plainfield

Managed 3/28/2014 26,500

Plainfield, IL

Legacy Ranch Alzheimer’s Special Care Center

Managed 3/28/2014 11,500 (2)

Midland, TX

The Springs Alzheimer’s Special Care Center

Managed 3/28/2014 10,500 (2)

San Angelo, TX

$ 190,612

FOOTNOTES:

(1) This represents a single property acquisition that is not considered material to the Company and as such no pro forma financial information has been included related to this property.
(2) This purchase price does not reflect subsequent contingent purchase price consideration paid related to the acquisition of these properties; refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 for the final purchase price of these properties.

11


3. Acquisitions (continued)

The following summarizes the purchase price allocation for the above properties, and the estimated fair values of the assets acquired and liabilities assumed (in thousands):

March 31,
2015 2014

Land and land improvements

$ 3,032 $ 18,446

Buildings and building improvements

63,825 154,607

Furniture, fixtures and equipment

455 5,572

Intangibles (1)

10,298 15,259

Other liabilities

(1,050 ) (702 )

Net assets acquired

76,560 193,182

Contingent purchase price consideration

(2,570 )

Total purchase price consideration

$ 76,560 $ 190,612

FOOTNOTE:

(1) At the acquisition date, the weighted-average amortization period on the acquired lease intangibles for the three months ended March 31, 2015 and 2014 was approximately 12.3 years and 3.0 years, respectively. The acquired lease intangibles during the three months ended March 31, 2015 were comprised of approximately $8.5 million and $1.8 million of in-place lease intangibles and other lease intangibles, respectively, and the acquired lease intangibles during the three months ended March 31, 2014 were comprised of approximately $15.2 million and $0.02 million of in-place lease intangibles and other lease intangibles, respectively.

12


3. Acquisitions (continued)

The revenues and net loss (including deductions for acquisition fees and expenses and depreciation and amortization expense) attributable to the acquired properties included in the Company’s condensed consolidated statements of operations were approximately $0.3 million and $0.5 million, respectively, for the three months ended March 31, 2015; and approximately $3.3 million, respectively, and $6.4 million, respectively, for the three months ended March 31, 2014.

The following table presents the unaudited pro forma results of operations for the Company as if the properties were acquired as of January 1, 2014 and owned during the three months ended March 31, 2015 and 2014 (in thousands except per share data):

(Unaudited)
Three Months Ended
March 31,
2015 2014

Revenues

$ 65,442 $ 37,077

Net income (loss) (1)

$ (17,465 ) $ (9,656 )

Loss per share of common stock (basic and diluted)

$ (0.13 ) $ (0.15 )

Weighted average number of shares of common stock outstanding (basic and diluted) (2)

129,627 65,273

FOOTNOTES:

(1) The unaudited pro forma results for the three months ended March 31, 2015, were adjusted to exclude approximately $0.7 million of acquisition related expenses directly attributable to the properties acquired during the three months ended March 31, 2015. The unaudited pro forma results for the three months ended March 31, 2014 were adjusted to include these acquisition related expenses, as if the properties had been acquired on January 1, 2014. The unaudited pro forma results for the three months ended March 31, 2014 were adjusted to exclude approximately $6.4 million of acquisition related expenses directly attributable to the properties acquired during the three months ended March 31, 2014, as if the properties had been acquired as of January 1, 2013.
(2) No additional shares were required to be issued as a result of the acquired properties. The weighted average shares outstanding was not adjusted as of January 1, 2014.

13


4. Real Estate Assets, net

The gross carrying amount and accumulated depreciation of the Company’s real estate assets as of March 31, 2015 and December 31, 2014 are as follows (in thousands):

March 31,
2015
December 31,
2014

Land and land improvements

$ 131,713 $ 128,662

Building and building improvements

1,609,713 1,545,614

Furniture, fixtures and equipment

38,265 36,319

Less: accumulated depreciation

(66,712 ) (53,095 )

Real estate investment properties, net

1,712,979 1,657,500

Real estate under development, including land

66,013 47,153

Total real estate assets, net

$ 1,778,992 $ 1,704,653

Depreciation expense on the Company’s real estate investment properties, net was approximately $13.6 million and $7.6 million for the three months ended March 31, 2015 and 2014, respectively.

As of March 31, 2015, four of the Company’s senior housing communities have real estate under development with third-party developers as follows (in thousands):

Property Name

(and Location)

Developer Real Estate
Development

Costs Incurred (1)
Remaining
Development
Budget
(2)

Wellmore of Tega Cay
(Tega Cay, SC)

Maxwell Group, Inc. $ 29,148 $ 10,959

HarborChase of Shorewood
(Shorewood, WI)

Harbor Shorewood

Development, LLC

15,095 11,979

Watercrest at Katy
(Katy, TX) (3)

South Bay Partners, Ltd 12,730 27,692

Raider Ranch
(Lubbock, TX)

South Bay Partners, Ltd 9,040 8,524

$ 66,013 $ 59,154

FOOTNOTES:

(1) This amount represents land and total capitalized costs for GAAP purposes for the acquisition, development and construction of the senior housing community as of March 31, 2015. Amounts include investment services fees, asset management fees, interest expense and other costs capitalized during the development period.
(2) This amount includes preleasing and marketing costs which will be expensed as incurred.
(3) This property is owned through a joint venture in which the Company’s initial ownership interest is 95%.

The development budgets of the senior housing developments include the cost of the land, construction costs, development fees, financing costs, start-up costs and initial operating deficits of the respective properties. An affiliate of the developer of the respective community coordinates and supervises the management and administration of the development and construction. Each developer is responsible for any cost overruns beyond the approved development budget for the applicable project pursuant to a cost overrun guarantee. These developments were deemed to be VIEs; refer to Note 7. “Variable Interest Entities” for additional information.

14


5. Intangibles, net

The gross carrying amount and accumulated amortization of the Company’s intangible assets and liabilities as of March 31, 2015 and December 31, 2014 are as follows (in thousands):

March 31,
2015
December 31,
2014

In-place lease intangibles

$ 147,574 $ 148,880

Above-market lease intangibles

11,625 11,320

Below-market ground lease intangibles

11,846 10,314

Less: accumulated amortization

(40,490 ) (30,250 )

Intangible assets, net

$ 130,555 $ 140,264

Below-market lease intangibles

$ (8,594 ) $ (13,243 )

Above-market ground lease intangibles

(2,864 ) (2,273 )

Less: accumulated amortization

1,446 1,014

Intangible liabilities, net (1)

$ (10,012 ) $ (14,502 )

FOOTNOTE:

(1) Intangible liabilities, net are included in other liabilities in the accompanying condensed consolidated balance sheets.

As of March 31, 2015, a tenant, who leases two of the Company’s specialty hospitals, was not current under its lease obligations with an outstanding rent receivable of approximately $0.3 million. Due to the uncertainty of the tenant’s ability to meet its future obligations under the leases, the Company recorded an impairment provision of approximately $5.5 million related to the lease intangibles and deferred rent assets as it was determined that the carrying value of these assets would more than likely not be recoverable. The Company also recorded an allowance to fully reserve the aforementioned rent receivable as of March 31, 2015. In addition, the Company assessed the underlying real estate assets for impairment and concluded that no adjustment to the carrying value was necessary as of March 31, 2015 based on the Company’s expected holding period and the estimated undiscounted cash flows and estimated net sales proceeds that could be generated by the property.

15


5. Intangibles, net (continued)

Amortization on the Company’s intangible assets was approximately $10.2 million for the three months ended March 31, 2015, of which approximately $0.5 million was treated as a reduction of rental income from operating leases, approximately $0.1 million was treated as an increase of property operating expenses and approximately $9.7 million was included in depreciation and amortization. Amortization on the Company’s intangible assets was approximately $4.5 million for the three months ended March 31, 2014, of which approximately $0.2 million was treated as a reduction of rental income from operating leases, approximately $0.03 million was treated as an increase of property operating expenses and approximately $4.2 million was included in depreciation and amortization.

Amortization on the Company’s intangible liabilities was approximately $0.4 million for the three months ended March 31, 2015, of which approximately $0.4 million was treated as an increase of rental income from operating leases and approximately $0.02 million dollars was treated as a reduction of property operating expenses. For the three months ended March 31, 2014, amortization on the Company’s intangible liabilities was approximately $0.1 million, of which approximately $0.1 million was treated as an increase of rental income from operating leases and approximately two thousand dollars was treated as a reduction of property operating expenses.

The estimated future amortization on the Company’s intangibles for the remainder of 2015, each of the next four years and thereafter, in the aggregate, as of March 31, 2015 is as follows (in thousands):

In-place
Lease
Intangibles
Above-
market
Leases
Below-
market
Ground
Leases
Total
Assets
Below-
market
Leases
Above-
market
Ground
Leases
Total
Liabilities

2015

$ 27,251 1,400 228 $ 28,879 $ (935 ) (55 ) $ (990 )

2016

25,861 1,527 304 27,692 (1,112 ) (73 ) (1,185 )

2017

12,963 1,391 304 14,658 (985 ) (73 ) (1,058 )

2018

10,212 1,243 304 11,759 (867 ) (73 ) (940 )

2019

7,416 1,007 304 8,727 (703 ) (73 ) (776 )

Thereafter

25,270 3,403 10,167 38,840 (2,577 ) (2,486 ) (5,063 )

$ 108,973 9,971 11,611 $ 130,555 $ (7,179 ) (2,833 ) $ (10,012 )

Weighted average remaining useful life as of March 31, 2015 (in years):

In-place
Lease
Intangibles

Above-
market
Leases
Below-
market
Ground
Leases
Below-
market
Leases
Above-
market
Ground
Leases
5.4 6.0 38.2 10.8 38.8

16


6. Operating Leases

As of March 31, 2015, the Company owned 57 properties that were leased to tenants on a triple-net, net or modified gross basis, and accounted for as operating leases; of which, 24 are single-tenant properties that are 100% leased under operating leases and the remaining 33 are multi-tenant properties that are leased under operating leases. The Company’s leases had a weighted average remaining lease term of 6.6 years based on annualized base rents expiring between 2015 and 2033, subject to the tenants’ options to extend the lease periods ranging from two to ten years. In addition, certain tenants hold options to extend their leases for multiple periods.

Under the terms of the Company’s triple-net lease agreements, each tenant is responsible for the payment of property taxes, general liability insurance, utilities, repairs and maintenance, including structural and roof maintenance expenses. Each tenant is expected to pay real estate taxes directly to taxing authorities. However, if the tenant does not pay, the Company will be liable. The total annualized property tax assessed on these properties is approximately $1.9 million.

Under the terms of the multi-tenant lease agreements that have third-party property managers, each tenant is responsible for the payment of their proportionate share of property taxes, general liability insurance, utilities, repairs and common area maintenance. These amounts are billed monthly and recorded as tenant reimbursement income in the accompanying consolidated statements of operations.

The following are future minimum lease payments to be received under non-cancellable operating leases for the remainder of 2015, each of the next four years and thereafter, as of March 31, 2015 (in thousands):

2015

$ 59,622

2016

75,451

2017

71,805

2018

67,852

2019

58,901

Thereafter

215,715

$ 549,346

The above future minimum lease payments to be received excludes tenant reimbursements, straight-line rent adjustments, amortization of above- and below-market lease intangibles and base rent attributable to any renewal options exercised by the tenants in the future. In addition, future minimum lease payments related to the two specialty hospitals have been excluded; refer to Note 5. “Intangibles, net” for additional information.

17


7. Variable Interest Entities

Consolidated VIEs – As of March 31, 2015, the Company has 16 wholly-owned subsidiaries, which are VIEs due to following factors and circumstances:

(1) Five of these subsidiaries are single property entities, designed to own and lease their respective properties to single tenants, for which buy-out options are held by the respective tenants that are formula based.

(2) Four of these subsidiaries are single property entities, designed to own and lease their respective properties to multiple tenants, which are subject to either a ground lease or an air rights lease that include buy-out and put options held by either the tenant or landlord under the applicable lease.

(3) Five of these subsidiaries are entities with real estate under development or completed developments in which the third-party developers have an opportunity to earn promoted interest payments after certain net operating income targets and internal rate of return targets have been met.

(4) One of these subsidiaries is a joint venture with real estate under development in which the third-party developer has an opportunity to earn promoted interest payments after certain net operating income targets and internal rate of return targets have been met.

(5) One of these subsidiaries is a joint venture with equity interest that consists of non-substantive voting rights.

The Company determined it is the primary beneficiary and holds a controlling financial interest in each of the aforementioned property and development entities due to its power to direct the activities that most significantly impact the economic performance of the entities, as well as its obligation to absorb the losses and its right to receive benefits from these entities that could potentially be significant to these entities. As such, the transactions and accounts of these VIEs are included in the accompanying consolidated financial statements.

The aggregate carrying amount and major classifications of the consolidated assets that can be used to settle obligations of the VIEs and liabilities of the consolidated VIEs that are non-recourse to the Company as of March 31, 2015 and December 31, 2014 are as follows (in thousands):

March 31,
2015
December 31,
2014

Assets:

Real estate investment properties, net

$ 173,192 $ 174,449

Real estate under development, including land

$ 66,013 $ 47,153

Intangibles, net

$ 24,673 $ 25,519

Cash

$ 3,911 $ 6,280

Other assets

$ 1,974 $ 511

Loan costs, net

$ 2,243 $ 2,300

Deferred rent and lease incentives

$ 3,296 $ 2,978

Restricted cash

$ 2,594 $ 5,304

Liabilities:

Mortgages and other notes payable

$ 146,298 $ 137,754

Accounts payable and accrued expenses

$ 2,435 $ 2,317

Accrued development costs

$ 9,181 $ 7,951

Due to related parties

$ 109 $ 219

Other liabilities

$ 5,756 $ 4,949

The Company’s maximum exposure to loss as a result of its involvement with these VIEs is limited to its net investment in these entities which totaled approximately $113.1 million as of March 31, 2015. The Company’s exposure is limited because of the non-recourse nature of the borrowings of the VIEs.

18


8. Ground and Air Rights Leases

During the three months ended March 31, 2015, in conjunction with the Novi Orthopaedic Center and UT Cancer Institute detailed in Note 3. “Acquisitions,” the Company acquired interests in two additional ground leases. The Novi Orthopaedic Center and UT Cancer Institute ground leases represent operating leases with scheduled payments over the life of the respective lease expiring in 2096 and 2076, respectively.

Overall, under the terms of its ground and air rights lease agreements, the Company is responsible for the monthly rental payments. These amounts are billed monthly and recorded as property operating expenses in the accompanying consolidated statements of operations. In some cases, the Company is able to pass this expense through to its tenants as tenant reimbursement income. For the three months ended March 31, 2015 and 2014, the Company incurred approximately $0.6 million and $0.1 million, respectively, in ground and air rights lease expense, including any straight-line rent adjustments.

The following is a schedule of future minimum lease payments to be paid under the ground and air rights leases for the remainder of 2015, each of the next four years and thereafter, in the aggregate, as of March 31, 2015 (in thousands):

2015

$ 1,231

2016

1,665

2017

1,706

2018

1,752

2019

1,777

Thereafter

120,533

$ 128,664

19


9. Contingent Purchase Price Consideration

Capital Health Communities

In connection with the acquisition of the Capital Health Communities in 2012, the Company required that approximately $7.0 million of the purchase price be placed in an escrow account as the seller guaranteed the Company an annual return of at least $6.9 million, $7.0 million, and $7.1 million of net operating income on the acquired properties during 2013, 2014 and 2015, respectively (“Yield Guaranty”). As of March 31, 2015, the Company determined the fair value of the Yield Guaranty to be $4.1 million, which was recorded as other assets in the accompanying condensed consolidated balance sheet. The following table provides a roll-forward of the fair value of the contingent purchase price consideration related to the Yield Guaranty on the Capital Health Communities for the three months ended March 31, 2015 and 2014 (in thousands):

Three Months Ended
March 31,
2015 2014

Beginning balance

$ 4,078 $ 4,488

Yield Guaranty payment received from seller

(2,300 )

Ending balance

$ 4,078 $ 2,188

South Bay II Communities

In conjunction with the acquisition of the South Bay II Communities, the Company entered into an agreement with the sellers whereby the purchase price is adjusted in the event that certain net operating income targets are met. The additional consideration was determined within three months of the acquisition date and is equal to (a) the baseline net operating income divided by the baseline capitalization rates (as defined in the purchase and sale agreement) less (b) the purchase price paid at closing. The following table provides a roll-forward of the fair value of the estimated contingent purchase price consideration related to the South Bay II Communities for the three months ended March 31, 2015 and 2014 (in thousands):

Three Months Ended
March 31,
2015 2014

Beginning balance

$ $

Contingent consideration in connection with acquisition

2,570

Ending balance

$ $ 2,570

Fair Value Measurements

The fair value of the contingent purchase price consideration was based on a then-current income approach that is primarily determined based on the present value and probability of future cash flows using internal underwriting models. The income approach further includes estimates of risk-adjusted rate of return and capitalization rates for each property. Since this methodology includes inputs that are less observable by the public and are not necessarily reflected in active markets, the measurements of the estimated fair value related to the Company’s contingent purchase price consideration are categorized as Level 3 on the three-level fair value hierarchy.

20


10. Indebtedness

The following table provides details of the Company’s indebtedness as of March 31, 2015 and December 31, 2014 (in thousands):

March 31,
2015
December 31,
2014

Mortgages payable and other notes payable:

Fixed rate debt

$ 375,889 $ 370,854

Variable rate debt (1)

462,138 482,922

Mortgages and other notes payable

838,027 853,776

Premium (discount), net (2)

(180 ) (215 )

Total mortgages and other notes payable, net

837,847 853,561

Credit facilities:

Term Loan Facility (1)

175,000 175,000

Revolving Credit Facility (3)

31,403

Total borrowings

$ 1,012,847 $ 1,059,964

FOOTNOTES:

(1) As of March 31, 2015 and December 31, 2014, the Company had entered into interest rate swaps with notional amounts of approximately $194.5 million and $182.1 million, respectively, which were settling on a monthly basis. In addition, as of March 31, 2015 and December 31, 2014, the Company had entered into forward-starting interest rate swaps for total notional amounts of approximately $365.7 million and $269.4 million, respectively, in order to hedge its exposure to variable rate debt in future periods. The remaining forward-starting interest rate swaps have a range of effective dates beginning in 2015 and continuing through the maturity date of the loan being hedged (ranging from 2016 through 2019).
(2) Premium (discount), net is reflective of the Company recording mortgage note payables assumed at fair value on the respective acquisition date.
(3) As of March 31, 2015 and December 31, 2014, availability under the Revolving Credit Facility was approximately $54.1 million and $14.0 million, respectively, based on the value of the properties in the unencumbered collateral pool of assets supporting the loan.

Maturities of indebtedness for the remainder of 2015, each of the next four years and thereafter, in the aggregate, as of March 31, 2015 are as follows (in thousands):

2015

$ 13,566

2016

70,185

2017

37,425

2018

297,292

2019

451,690

Thereafter

142,689

$ 1,012,847

21


10. Indebtedness (continued)

The Company financed previous acquisitions through additional mortgage loans and draws on existing construction loans. The following table provides details as of March 31, 2015 (in thousands):

Property and Loan Type

Interest Rate at

March 31,

2015 (1)

Payment Terms

Maturity
Date (2)
March 31,
2015

ProMed Medical Building I;

Mortgage Loan

3.64%

per annum (3)

Monthly principal and interest payments based upon a 30-year amortization schedule 1/15/22 $ 7,184

Total fixed rate debt 7,184

Raider Ranch Development;

Construction Loan

30-day

LIBOR plus 3.50% at

0.5% LIBOR floor

Monthly interest only payments through October 2017; principal and interest payments thereafter based on a 25-year amortization schedule 10/27/17 786

HarborChase of Shorewood;

Construction Loan

30-day LIBOR

plus 3%;

2% all in floor

Monthly interest only payments through July 2017; principal and interest payments thereafter based on a 25-year amortization schedule 7/15/19 2,463

Watercrest at Katy;

Construction Loan

30-day LIBOR

plus 2.75%

per annum

Monthly interest only payments through December 2017; principal and interest payments thereafter based on a 30-year amortization schedule 12/27/19 1

Total variable rate debt 3,250

Fixed and variable rate debt 10,434
Premium (discount), net

Total debt

$ 10,434

FOOTNOTES:

(1) The 30-day LIBOR was approximately 0.18% as March 31, 2015.
(2) Represents the initial maturity date (or, as applicable, the maturity date as extended). The maturity date may be extended beyond the date shown subject to certain lender conditions.
(3) Beginning January 2020, the interest rate transitions to variable rate based on 30-day LIBOR plus 2.20% per annum.

In March 2015, the Company repaid its $30.0 million outstanding mortgage loan on the Perennial Communities prior to its scheduled maturity. In connection therewith, the Company wrote-off approximately $0.2 million in unamortized loan costs as interest expense and loan cost amortization in the accompanying condensed consolidated statements of operations. In addition, the corresponding interest rate swap was terminated and approximately $0.1 million related to the derecognition of the cash flow hedge was reclassified from other comprehensive loss to interest expense and loan cost amortization in the accompanying condensed consolidated financial statements.

22


10. Indebtedness (continued)

In December 2014, the Company amended and restated the terms of its credit agreement with KeyBank, as administrative agent, by entering into a $230 million Revolving Credit Facility and a $175 million Term Loan Facility. Pursuant to the Amended Credit Agreement, the Company has the ability to increase the collective borrowings under the Credit Facilities to $700 million. Moreover, the Revolving Credit Facility has an initial term of 36 months plus two 12-month extension options; whereas, the Term Loan Facility has an initial term of 50 months plus one 12-month extension option. The Credit Facilities bear interest based on LIBOR and a spread that varies with the Company’s. In addition, the Company is required to make interest only payments until the respective maturity dates of the Credit Facilities as well as to pay fees ranging from 0.15% to 0.25% for unused commitments on the Revolving Credit Facility.

The Credit Facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured and unsecured indebtedness, and (vi) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the Credit Facilities, minimum debt service coverage ratio, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions includes a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the Credit Facilities) and the minimum amount of distributions required to maintain the Company’s REIT status.

All of the Company’s mortgage and construction loans contain customary financial covenants and ratios; including (but not limited to): debt service coverage ratio, minimum occupancy levels, limitations on incurrence of additional indebtedness, etc. As of March 31, 2015, the Company was in compliance with all financial covenants and ratios. However, as a result of the tenant default discussed in Note 5. “Intangibles, net,” the Company is monitoring the potential impact to the required debt service payments on the mortgage loan secured by the two specialty hospitals as the related loan agreements contain a clause that, if certain lease coverage thresholds are not maintained by the tenant on a trailing six-month basis, could require the Company to re-amortize the mortgage loan from a 25-year to a 15-year amortization period and require the escrow of property taxes and insurance. As of March 31, 2015 and through the date of this filing, the Company is not able to determine with certainty if the tenant has met the required lease coverage thresholds as required under the mortgage loan. However, as a result of the tenant’s default of its obligations under the leases, the Company does not believe the tenant currently meets the required lease coverage thresholds or will be able to do so in the future. Therefore, the Company anticipates that its required debt service payments related to these properties could be accelerated as a result of any continued default by the tenant.

The fair market value and carrying value of the mortgage and other notes payable was approximately $864.5 million and $837.8 million, respectively, and both the fair market value and carrying value of the Credit Facilities was $175.0 million as of March 31, 2015. The fair market value and carrying value of the mortgage and other notes payable was approximately $868.5 million and $853.6 million, respectively, and both the fair market value and carrying value of the Credit Facilities was $206.4 million as of December 31, 2014. These fair market values are based on current rates and spreads the Company would expect to obtain for similar borrowings. Since this methodology includes inputs that are less observable by the public and are not necessarily reflected in active markets, the measurement of the estimated fair values related to the Company’s mortgage notes payable is categorized as level 3 on the three-level valuation hierarchy. The estimated fair value of accounts payable and accrued expenses approximates the carrying value as of March 31, 2015 and December 31, 2014 because of the relatively short maturities of the obligations.

23


11. Related Party Arrangements

In March 2013, the Company entered into the Advisor Expense Support Agreement, whereby commencing on April 1, 2013, the Advisor has agreed to provide expense support to the Company through forgoing the payment of fees in cash and acceptance of restricted stock for services rendered and specified expenses incurred in an amount equal to the positive excess, if any, of (a) aggregate stockholder cash distributions declared for the applicable quarter, over (b) the Company’s aggregate modified funds from operations (as defined in the Advisor Expense Support Agreement). The Advisor expense support amount is determined for each calendar quarter of the Company, on a non-cumulative basis, each quarter-end date (“Determination Date”). In August 2013, the Company entered into the Property Manager Expense Support Agreement, whereby commencing on July 1, 2013, the Property Manager agreed to provide expense support to the Company through forgoing the payment of fees in cash and accepting restricted stock for services in an amount equal to the positive excess, if any, of (a) aggregate stockholder cash distributions declared for the applicable quarter, over (b) the Company’s aggregate modified funds from operations (as defined in the Property Manager Expense Support Agreement). The Property Manager expense support amount shall be determined, on a non-cumulative basis, after the calculation of the Advisor expense support amount pursuant to the Property Manager Expense Support Agreement on each Determination Date. The terms of both the Advisor Expense Support Agreement and the Property Manager Expense Support Agreement (‘the Expense Support Agreements”) automatically renews for consecutive one year periods, subject to the right of the Advisor or Property Manager to terminate their respective agreements upon 30 days’ written notice to the Company.

In exchange for services rendered and in consideration of the expense support provided, the Company will issue, within 45 days following each Determination Date, a number of shares of restricted stock equal to the quotient of the expense support amount provided by to the Advisor and Property Manager for the preceding quarter divided by the then-current public offering price per share of common stock, on the terms and conditions and subject to the restrictions set forth in the respective expense support agreements (“Expense Support Agreements”). Any amounts settled, and for which restricted stock shares are issued, pursuant to the Expense Support Agreements will be permanently waived and the Company will have no obligation to pay such amounts to the Advisor or the Property Manager. The Restricted Stock is subordinated and forfeited to the extent that stockholders do not receive their original invested capital back with at least a 6% annualized return of investment upon ultimate liquidity of the Company. Since the vesting criteria is outside the control of the Advisor and Property Manager and involves both market conditions and counterparty performance conditions, the restricted stock shares will be treated as unissued for financial reporting purposes until the vesting criteria, as defined in the Expense Support Agreements, are met.

The following fees were settled and paid in the form of Restricted Stock in connection with the Expense Support Agreements for the three months ended March 31, 2015 and 2014, and cumulatively as of March 31, 2015 (in thousands, except offering price):

Three Months
Ended March 31,
As of
March 31,
2015 2014 2015

Asset management fees (1)

$ 545 $ 848 $ 6,814

Then-current offering price (2)

$ 10.58 $ 10.14 $ 10.58

Restricted stock shares (3)

52 84 670

Cash distributions on Restricted Stock (4)

$ 54 $ 5 $ 157

Stock distributions on Restricted Stock (5)

4 (6) 11

24


11. Related Party Arrangements (continued)

FOOTNOTES:

(1) No other amounts have been settled in accordance with the Expense Support Agreements for the three months ended March 31, 2015 and 2014, and cumulatively as of March 31, 2015.
(2) The then-current offering prices are based on the Company’s net asset value (“NAV”) per share as of the Determination Date.
(3) Restricted stock shares are comprised of approximately 0.05 million issuable to the Advisor as of March 31, 2015. No fair value was assigned to the restricted stock shares as the shares were valued at zero, which represents the lowest possible value estimated at vesting. In addition, the restricted stock shares were treated as unissued for financial reporting purposes because the vesting criteria had not been met through March 31, 2015.
(4) The cash distributions have been recognized as compensation expense as issued and included in general and administrative expense in the accompanying condensed consolidated statements of operations.
(5) The par value of the stock distributions has been recognized as compensation expense as issued and included in general and administrative expense in the accompanying condensed consolidated statements of operations.
(6) During the three months ended March 31, 2014, the Advisor received 358 shares in the form of stock distributions under the terms of the Advisor Expense Support Agreement.

The Company maintains accounts totaling approximately $0.1 million as of both March 31, 2015 and December 31, 2014, at a bank in which the Company’s chairman serves as a director.

In March 2015, the Company acquired Fieldstone Memory Care, a 40-unit memory care community located in Yakima, Washington for a purchase price of $12.4 million from a related party of the Company’s Sponsor. The board of directors, including all of the independent directors, concluded that substantial justification existed to consummate the Fieldstone Memory Care acquisition, and that the transaction and the purchase price are fair and reasonable. In determining whether to approve the Fieldstone Transaction, the board of directors reviewed and took into account, among other factors it deemed appropriate, the following information, facts and circumstances: an affiliate of CNL is the majority interest holder and managing member of the seller; that the purchase price exceeds the seller’s acquisition and development costs; a March 2015 independent appraisal; and a prospective value upon reaching stabilization.

In June 2013, the Company originated an acquisition, development and construction loan (“ADC Loan”) to C4 Development, LLC (“Crosland Southeast”), a related party by virtue of a family relationship between a principal of the borrower and the Company’s vice chairman who recused himself from review and approval of the investment, for the development of an MOB in Rutland, Virginia that will function as an out-patient emergency and imaging center and was leased to Hospital Corporation of America (“HCA”). As of December 31, 2014, the Company’s ADC Loan had been fully repaid. For the three months ended March 31, 2014, the Company recorded interest income of approximately $0.1 million, which is included in interest income on note receivable from related party in the accompanying condensed consolidated statements of operations.

The Company incurs operating expenses which, in general, relate to administration of the Company on an ongoing basis. Pursuant to the advisory agreement, the Advisor shall reimburse the Company the amount by which the total operating expenses paid or incurred by the Company exceed, in any four consecutive fiscal quarters (“Expense Year”) commencing with the Expense Year ending June 30, 2013, the greater of 2% of average invested assets or 25% of net income (as defined in the advisory agreement) (“Limitation”), unless a majority of the Company’s independent directors determines that such excess expenses are justified based on unusual and non-recurring factors (“Expense Cap Test”). In performing the Expense Cap Test, the Company uses operating expenses on a GAAP basis after making adjustments for the benefit of expense support under the Expense Support Agreements. For the Expense Year ended March 31, 2015, the Company did not incur operating expenses in excess of the Limitation.

25


11. Related Party Arrangements (continued)

The fees incurred by and reimbursable to the Managing Dealer in connection with the Company’s Offering for the three months ended March 31, 2015 and 2014, and related amounts unpaid as of March 31, 2015 and December 31, 2014 are as follows (in thousands):

Three Months Ended
March 31,
Unpaid amounts as of (1)
March 31, December 31,
2015 2014 2015 2014

Selling commissions (2)

$ 4,022 $ 2,453 $ 77 $ 388

Marketing support fees (2)

5,387 2,584 141 555

$ 9,409 $ 5,037 $ 218 $ 943

The expenses and fees incurred by and reimbursable to the Company’s related parties for the three months ended March 31, 2015 and 2014, and related amounts unpaid as of March 31, 2015 and December 31, 2014 are as follows (in thousands):

Three Months Ended
March 31,
Unpaid amounts as of (1)
March 31, December 31,
2015 2014 2015 2014

Reimbursable expenses:

Offering costs (2)

$ 882 $ 826 $ 608 $ 713

Operating expenses (3)

898 199 877 479

Acquisition fees and expenses

104 235 12 80

1,884 1,260 1,497 1,272

Investment services fees (4)

1,416 4,046

Property management fees (5)

980 460 514 429

Asset management fees (6)

4,886 2,666 1,116 355

$ 9,166 $ 8,432 $ 3,127 $ 2,056

FOOTNOTES:

(1) Amounts are recorded as due to related parties in the accompanying condensed consolidated balance sheets.
(2) Amounts are recorded as stock issuance and offering costs in the accompanying condensed consolidated statements of stockholders’ equity and redeemable noncontrolling interest.
(3) Amounts are recorded as general and administrative expenses in the accompanying condensed consolidated statements of operations.
(4) For the three months ended March 31, 2015 and 2014, the Company incurred approximately $1.4 million and $4.0 million, respectively. For the three months ended March 31, 2014, investment services fees of approximately $0.5 million were capitalized and included in real estate under development in the accompanying condensed consolidated balance sheets. No investment services fees were capitalized for the three months ended March 31, 2015. Investment service fees, that are not capitalized, are recorded as acquisition fees and expenses in the accompanying condensed consolidated statements of operations.
(5) For the three months ended March 31, 2015 and 2014, the Company incurred approximately $1.0 million and $0.5 million, respectively, in property and construction management fees payable to the Property Manager of which approximately $0.3 million and $0.1 million, respectively, in construction management fees were capitalized and included in real estate under development in the accompanying condensed consolidated balance sheets.
(6) For the three months ended March 31, 2015 and 2014, the Company incurred approximately $4.9 million and $2.7 million, respectively, in asset management fees payable to the Advisor of which approximately $0.5 million and $0.8 million, respectively, was settled in accordance with the terms of the Advisor Expense Support Agreement and approximately $0.1 million was capitalized for each period and included in real estate under development in the accompanying condensed consolidated balance sheets.

26


12. Derivative Financial Instruments

The following table summarizes the terms of the derivative financial instruments held by the Company or through its joint venture and the asset (liability) that has been recorded (in thousands):

Fair value
asset (liability) as of

Initial Notional Amount

Strike (1) Credit
Spread (1)
Trade
date
Forward
date
Maturity
date
March 31,
2015
December 31,
2014

$12,421 (2)

1.3 % 2.6 % 1/17/2013 1/15/2015 1/16/2018 $ (142 ) $ (71 )

$38,255 (2)

2.7 % 2.5 % 9/6/2013 8/17/2015 7/10/2018 $ (1,626 ) $ (1,228 )

$26,067 (2)

2.8 % 2.5 % 9/6/2013 8/17/2015 8/29/2018 $ (1,193 ) $ (906 )

$30,000 (2)

1.1 % 2.7 % 10/22/2013 8/5/2015 8/19/2016 $ (162 ) $ (82 )

$29,952 (2)

0.9 % 4.3 % 11/13/2013 5/11/2015 5/31/2016 $ $ (74 )

$11,000 (3)

3.0 % % 6/27/2014 6/30/2014 6/30/2017 $ 4 $ 10

$48,415 (2)

2.4 % 2.9 % 8/15/2014 6/1/2016 6/2/2019 $ (795 ) $ (270 )

$84,251 (2)

2.3 % 2.4 % 9/12/2014 8/1/2015 7/15/2019 $ (2,431 ) $ (1,326 )

$7,129 (2)

1.2 % 2.3 % 11/12/2014 11/15/2014 10/15/2017 $ (67 ) $ (35 )

$175,000 (2)

1.6 % 2.0 % 12/23/2014 12/19/2014 2/19/2019 $ (2,552 ) $ (881 )

$138,698 (2)

1.7 % 2.0 % 1/9/2015 12/10/2015 12/22/2019 $ (1,099 ) $

FOOTNOTES:

(1) The all-in rates are equal to the sum of the Strike and Credit Spread detailed above.
(2) Amounts related to interest rate swaps held by the Company, or its equity method investments, which are recorded at fair value and included in either other assets or other liabilities in the accompanying consolidated balance sheets.
(3) Amounts related to the interest rate cap held by the Windsor Manor Joint Venture for which the proportionate amounts of fair value relative to the Company’s ownership percentage are included in investments in unconsolidated entities in the accompanying consolidated balance sheets.

Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by the Company and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative financial instruments and has determined that the credit valuation adjustments on the overall valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company determined that its derivative financial instruments valuation in its entirety is classified in Level 2 of the fair value hierarchy. Determining fair value requires management to make certain estimates and judgments. Changes in assumptions could have a positive or negative impact on the estimated fair values of such instruments which could, in turn, impact the Company’s or its joint venture’s results of operations.

27


13. Equity

Stockholders’ Equity:

Public Offering — The following table details the Company’s aggregate proceeds from its Offerings as of March 31, 2015 and December 31, 2014 (in millions):

March 31, 2015 December 31, 2014
Subscriptions Reinvestment Plan Subscriptions Reinvestment Plan
Proceeds Shares Proceeds Shares Proceeds Shares Proceeds Shares

Initial Offering

$ 1,271.4 125.1 $ 27.1 125.1 $ 1,114.2 110.2 $ 27.1 2.8

Follow-on Offering

23.5 2.2 7.6 0.8

$ 1,294.9 127.3 $ 34.7 125.9 $ 1,114.2 110.2 $ 27.1 2.8

Distributions — The following table details the Company’s historical share prices in its Offerings, including the prices pursuant to the Reinvestment Plan and the Company’s monthly cash and stock distributions per share:

Period

Offering Price
per Share
Reinvestment
Plan Price

per Share
Monthly
Cash
Distributions (1)
Monthly
Stock
Distributions

December 11, 2013 through November 3, 2014

$ 10.14 $ 9.64 $ 0.0338 0.0025

November 4, 2014 through date of this filing

$ 10.58 $ 10.06 $ 0.0353 0.0025

FOOTNOTE:

(1) Monthly cash distributions were effective and payable to all common stockholders of record as of the close of business on the first business day in the month subsequent to the announcement of the Company’s NAV (i.e. December 1, 2014 for the current Offering price).

During the three months ended March 31, 2015 and 2014, the Company declared cash distributions of $13.2 million and $6.1 million, respectively, of which $5.6 million and $2.8 million, were paid in cash to stockholders and $7.6 million and $3.3 million, respectively, were reinvested pursuant to the Reinvestment Plan. In addition, for the three months ended March 31, 2015 and 2014, the Company declared and made stock distributions of approximately 0.9 million and 0.5 million shares of common stock, respectively.

28


13. Equity (continued)

The tax composition of the Company’s distributions declared for the three months ended March 31, 2015 and 2014 were as follows:

Three Months Ended March 31,

Distribution Type

2015 2014

Taxable as ordinary income

48.9 % 20.0 %

Return of capital

51.1 % 80.0 %

Redemptions — During the three months ended March 31, 2015 and 2014, the Company received requests for the redemption of common stock of approximately 0.2 million and 0.03 million shares, respectively, all of which were approved for redemption at an average price of $9.51 and $9.13, respectively, and for a total of approximately $1.9 million and $0.3 million, respectively.

Other comprehensive loss — The following table reflects the effect of derivative financial instruments held by Company, or its equity method investments, and included in the condensed consolidated statements of comprehensive loss for the three months ended March 31, 2015 and 2014 (in thousands):

Derivative Financial

Instrument

Loss recognized in other
comprehensive loss

on derivative financial
instrument

(Effective Portion)

Location of loss

reclassified into

earnings

(Effective Portion)

Loss reclassified from
AOCI into earnings
(Effective Portion)
Three Months Ended
March 31,
Three Months Ended
March 31,
2015 2014 2015 2014

Interest rate swaps

$ (5,268 ) $ (223 )

Interest expense and

loan cost amortization

$ (659 ) $

Reclassification of interest rate

swaps upon derecognition

74 Interest expense and loan cost amortization (74 )

Interest rate cap held by

unconsolidated joint venture

(6 ) Not applicable

Interest rate swap held by

unconsolidated joint venture

(26 ) Not applicable

Total

$ (5,200 ) $ (249 ) $ (733 ) $

29


14. Commitments and Contingencies

From time to time the Company may be exposed to litigation arising from operations of its business in the ordinary course of business. Management is not aware of any litigation that it believes will have a material adverse impact on the Company’s financial condition or results of operations.

Refer to Note 4. “Real Estate Assets, net” for additional information on the remaining development budgets for the Company’s senior housing developments.

15. Subsequent Events

Equity transactions

During the period from April 1, 2015 through May 4, 2015, the Company received additional subscription proceeds of approximately $66.3 million (6.3 million shares).

The Company’s board of directors declared a monthly cash distribution of $0.0353 and a monthly stock distribution of 0.0025 shares on each outstanding share of common stock on April 1, 2015 and May 1, 2015. These distributions are to be paid and distributed by June 30, 2015.

30


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Caution Concerning Forward-Looking Statements

Certain statements under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this in this Quarterly Report on Form 10-Q for the three months ended March 31, 2015 (“Quarterly Report”) that are not statements of historical or current fact may constitute “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbor created by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are statements that do not relate strictly to historical or current facts, but reflect management’s current understandings, intentions, beliefs, plans, expectations, assumptions and/or predictions regarding the future of the Company’s business and its performance, the economy, and other future conditions and forecasts of future events, and circumstances. Forward-looking statements are typically identified by words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “continues,” “pro forma,” “may,” “will,” “seeks,” “should” and “could,” and words and terms of similar substance in connection with discussions of future operating or financial performance, business strategy and portfolios, projected growth prospects, cash flows, costs and financing needs, legal proceedings, amount and timing of anticipated future distributions, estimated per share net asset value of the Company’s common stock, and/or other matters. The Company’s forward-looking statements are not guarantees of future performance. While the Company’s management believes its forward-looking statements are reasonable, such statements are inherently susceptible to uncertainty and changes in circumstances. As with any projection or forecast, forward-looking statements are necessarily dependent on assumptions, data and/or methods that may be incorrect or imprecise, and may not be realized. The Company’s forward-looking statements are based on management’s current expectations and a variety of risks, uncertainties and other factors, many of which are beyond the Company’s ability to control or accurately predict. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, the Company’s actual results could differ materially from those set forth in the forward-looking statements due to a variety of risks, uncertainties and other factors.

Important factors that could cause the Company’s actual results to vary materially from those expressed or implied in its forward-looking statements include, but are not limited to, government regulation, economic, strategic, political and social conditions, and the following: risks associated with the Company’s investment strategy; a worsening economic environment in the U.S. or globally, including financial market fluctuations; risks associated with real estate markets, including declining real estate values; risks associated with reliance on the Company’s advisor and its affiliates, including conflicts of interest; the Company’s failure to obtain, renew or extend necessary financing or to access the debt or equity markets; the use of debt to finance the Company’s business activities, including refinancing and interest rate risk and the Company’s failure to comply with debt covenants; the Company’s inability to identify and close on suitable investments; failure to successfully manage growth or integrate acquired properties and operations; the Company’s inability to make necessary improvements to properties on a timely or cost-efficient basis; risks related to property expansions and renovations; risks related to development projects or acquired property value-add conversions, if applicable, including construction delays, cost overruns, the Company’s inability to obtain necessary permits, and/or public opposition to these activities; competition for properties and/or tenants; defaults on or non-renewal of leases by tenants; failure to lease properties on favorable terms or at all; the impact of current and future environmental, zoning and other governmental regulations affecting the Company’s properties; the impact of changes in accounting rules; the impact of regulations requiring periodic valuation of the Company on a per share basis; inaccuracies of the Company’s accounting estimates; unknown liabilities of acquired properties or liabilities caused by property managers or operators; material adverse actions or omissions by any joint venture partners; increases in operating costs and other expenses; uninsured losses or losses in excess of the Company’s insurance coverage; the impact of outstanding and/or potential litigation; risks associated with the Company’s tax structuring; failure to qualify for and maintain the Company’s REIT qualification; and the Company’s inability to protect its intellectual property and the value of its brand.

For further information regarding risks and uncertainties associated with the Company’s business, and important factors that could cause the Company’s actual results to vary materially from those expressed or implied in its forward-looking statements, please refer to the factors listed and described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the “Risk Factors” sections of the Company’s documents filed from time to time with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s quarterly reports on Form 10-Q and the Company’s annual report on Form 10-K, copies of which may be obtained from the Company’s website at www.cnlhealthcareproperties.com.

31


All written and oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by this cautionary note. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to, and expressly disclaims any obligation to, publicly release the results of any revisions to its forward-looking statements to reflect new information, changed assumptions, the occurrence of unanticipated subsequent events or circumstances, or changes to future operating results over time, except as otherwise required by law.

32


Introduction

The following discussion is based on the condensed consolidated financial statements as of March 31, 2015 (unaudited) and December 31, 2014. Amounts as of December 31, 2014, included in the unaudited condensed consolidated balance sheets have been derived from the audited consolidated financial statements as of that date. This information should be read in conjunction with the accompanying unaudited condensed consolidated balance sheets and the notes thereto, as well as the audited consolidated financial statements, notes and management’s discussion and analysis included in our annual report on Form 10-K for the year ended December 31, 2014.

Overview

CNL Healthcare Properties, Inc. is a Maryland corporation incorporated on June 8, 2010 that elected to be taxed as a REIT beginning with the year ended December 31, 2012 for U.S. federal income tax purposes. The terms “us,” “we,” “our,” “Company” and “CNL Healthcare Properties” include CNL Healthcare Properties, Inc. and each of its subsidiaries.

We are externally managed and advised by CNL Healthcare Corp. Our Advisor is responsible for managing our day-to-day affairs and for identifying and making acquisitions and investments on our behalf. We have also retained CNL Healthcare Manager Corp. to manage our properties under a six year property management agreement, which goes until June 8, 2017.

We had no operations prior to the commencement of our Initial Offering. The net proceeds from our Offerings are contributed to CHP Partners, LP, our operating partnership, in exchange for partnership interests. Substantially all of our assets are held by, and substantially all of our operations are conducted through, the operating partnership.

Our investment focus is on acquiring a diversified portfolio of healthcare real estate or real estate-related assets, primarily in the United States, within the senior housing, medical office, post-acute care and acute care asset classes. The types of senior housing that we may acquire include active adult communities (age-restricted and age-targeted housing), independent and assisted living facilities, continuing care retirement communities, and memory care facilities. The types of medical office facilities that we may acquire include medical office buildings, specialty medical and diagnostic service facilities, surgery centers, outpatient rehabilitation facilities, and other facilities designed for clinical services. The types of post-acute care facilities that we may acquire include skilled nursing facilities, long-term acute care hospitals and inpatient rehabilitative facilities. The types of acute care facilities that we may acquire include general acute care hospitals and specialty surgical hospitals. We view, manage and evaluate our portfolio homogeneously as one collection of healthcare assets with a common goal of maximizing revenues and property income regardless of the asset class or asset type.

We are committed to investing the proceeds of our Offerings through strategic investment types aimed to maximize stockholder value by generating sustainable cash flow growth and increasing the value of our healthcare assets. We expect to primarily lease senior housing properties to wholly-owned TRS entities and engage independent third-party managers under management agreements to operate the properties as permitted under RIDEA structures; however, we may also lease our properties to third-party tenants under triple-net or similar lease structures, where the tenant bears all or substantially all of the costs (including cost increases, for real estate taxes, utilities, insurance and ordinary repairs). Medical office, post-acute care and acute care properties will be leased on a triple-net, net or modified gross basis to third-party tenants. In addition, we expect most investments will be wholly owned, although, we have and may continue to invest through partnerships with other entities where we believe it is appropriate and beneficial. We have and may continue to invest in new property developments or properties which have not reached full stabilization. Finally, we also may invest in and originate mortgage, bridge or mezzanine loans or in entities that make investments similar to the foregoing investment types. We generally make loans to the owners of properties to enable them to acquire land, buildings, or to develop property. In exchange, the owner generally grants us a first lien or collateralized interest in a participating mortgage collateralized by the property or by interests in the entity that owns the property.

33


Portfolio Overview

We believe recent demographic trends and compelling supply and demand indicators present a strong case for an investment focus on the acquisition of healthcare real estate or real estate-related assets. We believe that the healthcare sector will continue to provide attractive opportunities as compared to other asset sectors over the long-term. Our healthcare investment portfolio is geographically diversified with properties in 29 states. The map below shows our current property allocations across geographic regions as of May 4, 2015:

LOGO

As of May 4, 2015, our healthcare investment portfolio consisted of interests in 103 properties, including 56 senior housing communities, 34 medical offices, nine post-acute care facilities and four acute care hospitals. Of our properties held at May 4, 2015, four of our 56 senior housing communities currently have real estate under development and five were owned through an unconsolidated joint venture. The following table summarizes our healthcare portfolio by asset class and investment structure as of May 4, 2015:

Type of Investment

Number of
Investments
Amount of Percentage
Investments
(in millions)
of Total
Investments

Consolidated investments:

Senior housing leased (1)

10 $ 157.1 7.7 %

Senior housing managed (2)

37 896.7 44.0 %

Senior housing developments (3)

4 66.0 3.2 %

Medical office leased (1)

34 641.8 31.5 %

Post-acute care leased (1)

9 124.3 6.1 %

Acute care leased (1)

4 122.1 6.0 %

Unconsolidated investments:

Senior housing managed (4)

5 31.1 1.5 %

103 $ 2,039.1 100.0 %

FOOTNOTES:

(1) Properties that are leased to third-party tenants for which we report rental income from operating leases.
(2) Senior housing communities are leased to TRSs and managed pursuant to third-party management contracts (i.e. RIDEA structure) where we report resident fees and services, and the corresponding property operating expenses.
(3) Investments herein represent funded and accrued development costs as of March 31, 2015.
(4) Properties that are owned through an unconsolidated joint venture and are leased to TRSs and managed pursuant to third-party management contracts (i.e. RIDEA structure). The joint venture is accounted for using the equity method.

34


Portfolio Evaluation

We monitor the performance of our tenants and third-party operators to stay abreast of any material changes in the operations of the underlying properties by (1) reviewing the current, historical and prospective operating margins (measured by a tenant’s earnings before interest, taxes, depreciation, amortization and facility rent), (2) monitoring trends in the source of our tenants’ revenue, including the relative mix of public payors (including Medicare, Medicaid, etc.) and private payors (including commercial insurance and private pay patients), (3) evaluating the effect of evolving healthcare legislation and other regulations on our tenants’ profitability and liquidity, and (4) reviewing the competition and demographics of the local and surrounding areas in which the tenants operate.

In addition to operating statistics of the underlying properties, when evaluating the performance of our healthcare portfolio within the senior housing and post-acute care asset classes, management reviews occupancy levels and monthly revenue per occupied unit (“RevPOU”), which we define as total revenue divided by average number of occupied units or beds during a month and is considered a performance metric within these asset classes. Similarly, within the medical office and acute care asset classes, management reviews operating statistics of the underlying properties, including occupancy levels and monthly revenue per square foot. Lastly, when evaluating the performance of our third-party operators or developers, management reviews monthly financial statements, property level operating performance versus budgeted expectations, conducts periodic operational review calls with operators and conducts periodic property inspections or site visits. All of the aforementioned metrics assist us in determining the ability of our properties or operators to achieve market rental rates, to assess the overall performance of our diversified healthcare portfolio, and to review compliance with leases, debt, licensure, real estate taxes, and other collateral.

Furthermore, in our evaluation of the properties that we have purchased and additional properties that we expect to purchase, we consider the operating stage of the investments within the following stages: development, value-add or stabilizing and stabilized. Development properties are those in which we or our joint venture have purchased land for the development of new operating properties. We typically hold rights as the owner or managing member of the development properties while a third-party or our joint venture partner manages the development, construction and certain day-to-day operations of the property subject to our oversight. Stabilizing properties are either developed properties that have been fully constructed and in lease-up phase (typically 18 months post-construction) or existing (“value-add”) properties in which we expect to make capital investments to upgrade or expand. A property is considered stabilized upon the earlier of (i) when the property reaches 85% occupancy for a trailing three month period, or (ii) a two year period from acquisition or completion of development. For those assets that are above an 85% occupancy level and subsequently drop below 85%, they are reclassified to stabilizing until they hit the trailing three month 85% occupancy metric.

We have increased the level of our investment in new ground up development and value-add or stabilizing properties. During the construction and lease up phase, these types of investments are expected to generate limited cash flows or losses from operations and may result in near term downward pressure on our net asset valuation. However, we believe that investing a portion of our capital into these types of properties is beneficial because they are expected to provide a higher yield on cost and higher net asset valuations in the long-term as compared to similar stabilized acquisitions. Additionally, these types of assets will result in our portfolio having a lower average age, which we believe will enhance our overall market value over the long-term.

Based on revenues as of March 31, 2015, the Company’s portfolio is comprised of 61.3% stabilized properties and 38.7% value-add or stabilizing properties, of which 3.1% are recently completed developments that are currently in the lease-up phase.

35


The following table lists our occupancy, RevPOU and revenue per square feet by asset class within our healthcare portfolio as of March 31, 2015:

Operating Stage

Occupancy % RevPOU Rent per
Square Feet

Value-add or Stabilizing:

Senior Housing

70.9 % $ 3,821 $

Medical Office

77.6 % $ $ 2.53

Stabilized:

Senior Housing

91.4 % $ 4,556 $

Medical Office

93.9 % $ $ 2.68

Acute

100.0 % $ $ 3.40

Post-Acute (1)

99.9 % $ 6,973 $ 2.67

FOOTNOTE:

(1) Post-acute is comprised of skilled nursing facilities, which are evaluated based on RevPOU, and inpatient rehab hospitals, which are evaluated based on revenue per square feet.

Real Estate Under Development

As of May 4, 2015, we had interests in four senior housing developments that will provide us with 528 additional units upon completion as follows:

Property Name

(and Location)

Developer Number of
Units upon
Completion
Development
Costs Incurred
(in millions) (1)
Remaining
Development
Budget

(in millions) (2)
Maximum
Construction
Loans
Available

(in millions)
Estimated
Completion
Date

Wellmore of Tega Cay

(Tega Cay, SC)

Maxwell Group, Inc. 152 units $ 29.2 $ 11.0 $ 10.9 3rd quarter
2015

HarborChase of Shorewood (Shorewood, WI)

Harbor Shorewood
Development, LLC
94 units 15.1 12.0 14.2 4th quarter
2015

Watercrest at Katy

(Katy, TX) (3)

South Bay Partners, Ltd 210 units 12.7 27.7 26.7 1st quarter
2016

Raider Ranch

(Lubbock, TX)

South Bay Partners, Ltd 72 units 9.0 8.5 9.0 1st quarter
2016

Total 528 units $ 66.0 $ 59.2 $ 60.8

FOOTNOTES:

(1) This amount represents land and total capitalized costs for GAAP purposes for the acquisition, development and construction of the senior housing community as of March 31, 2015. Amounts include investment services fees, asset management fees, interest expense and other costs capitalized during the development period.
(2) This amount includes preleasing and marketing costs which will be expensed as incurred.
(3) This property is owned through a joint venture in which the Company’s initial ownership interest is 95%.

The development budgets of the senior housing developments include the cost of the land, construction costs, development fees, financing costs, start-up costs and initial operating deficits of the respective properties. An affiliate of the developer of the respective community coordinates and supervises the management and administration of the development and construction. Each developer is responsible for any cost overruns beyond the approved development budget for the applicable project.

36


Significant Tenants and Operators

Our real estate portfolio is operated by a mix of national or regional operators and the following represents the significant tenants and operators that lease or manage 5% or more of our rentable space as of March 31, 2015:

Tenants

Number of
Properties
Rentable
Square Feet

(in thousands)
Percentage
of Rentable
Square Feet
Lease
Expiration Year

TSMM Management, LLC

10 945 25.8 % 2022

Novant Medical Group, Inc.

5 268 7.3 % 2025

Senior Living Centers

6 261 7.1 % 2023

Other tenants (1)

36 2,190 59.8 % 2015 - 2033

57 3,664 100.0 %

Operators

Number of
Properties
Rentable
Square Feet

(in thousands)
Percentage
of Rentable
Square Feet
Operator
Expiration Year

Integrated Senior Living, LLC

5 1,319 32.2 % 2024

Prestige Senior Living, LLC

13 895 21.8 % 2019

MorningStar Senior Management, LLC

4 834 20.3 % 2018

Harbor Retirement Associates, LLC

3 246 6.0 % 2018 - 2023

Jerry Erwin Associates, Inc.

4 235 5.7 % 2019

Generations - UT, LLC

1 229 5.6 % 2019

Capital Health Managers

5 225 5.5 % 2017

Other operators (1)

2 117 2.9 % 2019

37 4,100 100.0 %

FOOTNOTE:

(1) Comprised of various tenants or operators each of which comprise less than 5% of our rentable square footage.

While we are not directly impacted by the performance of the underlying properties leased to third-party tenants, we believe that the financial and operational performance of our tenants provides an indication about the health of our tenants and their ability to pay rent. To the extent that our tenants, managers or joint venture partners experience operating difficulties and become unable to generate sufficient cash to make rent payments to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Our tenants and managers are contractually required to provide this information to us in accordance with their respective lease, management and joint venture agreements. Therefore, in order to mitigate the aforementioned risk, we monitor our investments through a variety of methods determined by the type of property.

We monitor the credit of our tenants to stay abreast of any material changes in quality. We monitor tenant credit quality by (1) reviewing financial statements that are publicly available or that are required to be delivered to us under the applicable lease, (2) direct interaction with onsite property managers, (3) monitoring news and rating agency reports regarding our tenants (or their parent companies) and their underlying businesses, (4) monitoring the timeliness of rent collections and (5) monitoring lease coverage.

37


Tenant Lease Expirations

During the three months ended March 31, 2015, our rental revenues represented approximately 33.3% of our total revenues. As of March 31, 2015, approximately 61.7% of our rental revenues were scheduled to expire in 2020 or later. Based on this, we do not expect lease turnover or any increases in property operating expenses to have a significant impact on our cash flow from operations in the near term.

Our asset management team collaborates with existing tenants to understand their current and anticipated space needs in advance of their lease term renewal date. As of March 31, 2015, approximately 38.3% of our rental revenues from operating leases were scheduled to expire through 2019. We work with and begin lease-related negotiations well in advance of the lease expirations or renewal period options in order for us to maintain a balanced lease rollover schedule and high occupancy levels, as well as to enhance the value of our properties through extended lease terms. Lease extensions are likely to create an obligation to pay lease commissions, lease incentives and/or tenant improvements and may also provide our tenants with some periods of reduced and/or “free rent.” Certain amendments or modifications to the terms of existing leases could require lender approval.

The following table lists, on an aggregate basis, scheduled expirations for the remainder of 2015, the next nine years ending December 31st and thereafter on our consolidated healthcare investment portfolio (excludes real estate under development), assuming that none of the tenants exercise any of their renewal options (in thousands, except for number of tenants and percentages) as of March 31, 2015:

Year of

Expiration (1)

Number of
Tenants
Expiring Rentable
Square Feet
Expiring
Annualized
Base Rents
(2)
Percentage of
Expiring Annual
Base Rents

2015

68 233 $ 5,967 7.6 %

2016

49 177 4,477 5.7 %

2017

54 189 4,693 5.9 %

2018

81 326 8,011 10.1 %

2019

60 267 7,160 9.0 %

2020

29 194 4,581 5.8 %

2021

11 84 2,025 2.6 %

2022

16 991 14,155 17.9 %

2023

60 662 17,586 22.3 %

2024

4 80 2,125 2.7 %

Thereafter

16 318 8,240 10.4 %

Total

448 3,521 $ 79,020 100.0 %

Weighted Average Remaining Lease Term: (3 )

6.6 years

FOOTNOTES:

(1) Represents current lease expiration and does not take into consideration lease renewals available under existing leases at the option of the tenants.
(2) Represents the current base rent, excluding tenant reimbursements and the impact of future rent escalations included in leases, multiplied by 12 and included in the year of expiration.
(3) Weighted average remaining lease term is the average remaining term weighted by annualized current base rents.

38


Liquidity and Capital Resources

General

Our primary source of capital has been, and is expected to continue to be, proceeds we receive from our Offerings. Our principal demands for funds will be for:

the acquisition of real estate and real estate-related assets,

the payment of offering and operating expenses,

the payment of debt service on our outstanding indebtedness, and

the payment of distributions.

Generally, we expect to meet cash needs for items other than acquisitions from our cash flows from operations, and we expect to meet cash needs for acquisitions from net proceeds from our Offerings and borrowings. However, until such time as we are fully invested, we may continue to use proceeds from our Offerings and borrowings to pay a portion of our operating expenses, distributions and debt service.

We intend to strategically leverage our real properties and possibly other assets and use debt as a means of providing additional funds for the acquisition of properties and the diversification of our portfolio. Our ability to increase our diversification through borrowing could be adversely affected by credit market conditions which result in lenders reducing or limiting funds available for loans, including loans collateralized by real estate. We may also be negatively impacted by rising interest rates on any unhedged variable rate debt or the timing of when we seek to refinance existing debt. During times when interest rates on mortgage loans are high or financing is otherwise unavailable on a timely basis, we may purchase certain properties for cash with the intention of obtaining a mortgage loan for a portion of the purchase price at a later time. In addition, we will continue to evaluate the need for additional interest rate swaps on unhedged variable rate debt.

Potential future sources of capital include proceeds from collateralized or uncollateralized financings from banks or other lenders, proceeds from the sale of properties, other assets and undistributed operating cash flows. If necessary, we may use financings or other sources of capital in the event of unforeseen significant capital expenditures.

The number of properties, loans and other permitted investments we may acquire or make will depend on the number of shares sold through our Offerings of common stock and the resulting amount of the net offering proceeds available for investment.

Sources of Liquidity and Capital Resources

Common Stock Offering

For the three months ended March 31, 2015 and 2014, we received proceeds from our Offerings of approximately $180.7 million (17.1 million shares) and $86.8 million (8.7 million shares), respectively. During the period April 1, 2015 through May 4, 2015, we received additional subscription proceeds of approximately $66.3 million (6.3 million shares).

Our Follow-On Offering was declared effective on February 2, 2015 at which date, we ceased our Initial Offering and commenced our Follow-On Offering. We expect to sell shares of our common stock until the earlier of the date on which the maximum offering amount of $1 billion has been sold, or December 31, 2015; provided, however, that we will periodically evaluate the status of the offering, and our board of directors may extend the offering beyond December 31, 2015 after taking into account such factors as it deems appropriate, including but not limited to, the amount of capital raised, future acquisition opportunities, and economic or market trends.

As of March 31, 2015, we had unused proceeds from our Offerings of approximately $116.4 million as cash on hand. We plan to use the available uncommitted cash on hand as of March 31, 2015, as well as additional borrowings and offering proceeds obtained subsequently, to acquire additional healthcare real estate and real estate-related assets.

39


Borrowings

We have borrowed and intend to continue borrowing money to acquire properties, make loans and other permitted investments, fund ongoing enhancements to our portfolio, and to cover periodic shortfalls between distributions paid and cash flows from operating activities. During the three months ended March 31, 2015 and 2014, we borrowed approximately $18.2 million and $123.2 million, respectively. These amounts were primarily used to fund real estate under development and acquire additional properties, respectively. In addition, in January 2015, our consolidated joint venture obtained financing of approximately $7.1 million on ProMed Medical Building I.

As of March 31, 2015, we had availability under the Revolving Credit Facility of approximately $54.1 million, based on the value of the properties in the unencumbered collateral pool of assets supporting the loan. In addition, we had an aggregate debt leverage ratio of approximately 48.7%, based on the aggregate carrying value of our assets. We may borrow money to pay distributions to stockholders, for working capital and for other corporate purposes. See “Uses of Liquidity and Capital Resources – Distributions” below for additional information related to the payment of distributions with other sources for GAAP purposes. In many cases, we have pledged our assets in connection with our borrowings and intend to encumber assets in connection with additional borrowings. The aggregate amount of long-term financing is not expected to exceed 60% of our total assets on an annual basis.

In May 2015, we executed an amendment to our credit agreement with KeyBank, as administrative agent, related to the Credit Facilities, which adjusts certain criteria and terms for the unencumbered collateral pool of assets supporting our Revolving Credit Facility. The amendment will allow us to include the Perennial Communities and Medical Portfolio I Properties in the unencumbered collateral pool, which will increase our availability under the Revolving Credit Facility in future periods. Refer to “Uses of Liquidity and Capital Resources – Debt Repayments” for additional information related to the repayment of the secured mortgage loans on these properties.

As a result of the tenant default discussed in Note 5. “Intangibles, net,” we are monitoring the potential impact to the required debt service payments on our mortgage loan secured by two of our specialty hospitals as the related loan agreements contain a clause that, if certain lease coverage thresholds are not maintained by the tenant on a trailing six-month basis, could require us to re-amortize the mortgage loan from a 25-year to a 15-year amortization period and require the escrow of property taxes. As of March 31, 2015, we are not able to determine with certainty if the tenant has met the required lease coverage thresholds as required under the mortgage loan. However, as a result of the tenant’s default of its obligations under the leases, we do not believe the tenant currently meets the required lease coverage thresholds or will be able to do so in the future. Therefore, we anticipate that our required debt service payments on these properties could be accelerated as a result of any continued default by the tenant. Refer to Note 10. “Indebtedness” for additional information on our borrowings, including a schedule of future principal payments and maturity dates as of March 31, 2015.

Distributions from Unconsolidated Entities

As of March 31, 2015, we had an investment in five unconsolidated properties through a joint venture. Pursuant to the joint venture agreement, we are entitled to receive quarterly preferred cash distributions to the extent there is cash available to distribute. These distributions are generally received within 45 days after each quarter end. For the three months ended March 31, 2015, we received approximately $0.2 million of operating distributions from our investment in these unconsolidated entities.

For the three months ended March 31, 2014, we received approximately $0.6 million of operating distributions from our two investments in unconsolidated entities. In August 2014, we acquired our co-venture partner’s 10% interest in the Montecito Joint Venture for approximately $1.6 million. As a result, we own 100% of the Montecito Joint Venture and began consolidating all of the assets, liabilities and results of operations in our consolidated financial statements upon acquisition.

40


Net Cash Provided by Operating Activities

We generally expect to meet future cash needs for general and administrative expenses, debt service and distributions from the net operating income (“NOI”) from our properties, which primarily is rental income from operating leases, resident fees and services, tenant reimbursement income and interest income less the property operating expenses and property management fees from managed properties. We experienced positive cash flow from operating activities for the three months ended March 31, 2015 and 2014 of approximately $11.3 million and $6.3 million, respectively.

The increase in cash flows from operating activities for the three months ended March 31, 2015 as compared to the same period in 2014 was primarily the result of the following:

an increase in total revenues and NOI for the three months ended March 31, 2015, as compared to the three months ended March 31, 2014, primarily as the result of having 94 consolidated operating properties in 2015 as compared with 67 consolidated operating properties in 2014; and

a decrease in acquisition fees and expenses during the three months ended March 31, 2015, in which we acquired three consolidated operating properties during the period totaling $76.6 million, compared with the three months ended March 31, 2014, in which we purchased 10 consolidated operating properties totaling $190.6 million. The acquisition fees and expenses were funded by proceeds from our Offerings or debt proceeds and are treated as an operating activity in accordance with GAAP;

offset by a decrease in expense support of approximately $0.3 million related to asset management fees that were foregone by our Advisor under the Advisor Expense Support Agreement (discussed below).

As we continue to acquire additional properties we expect that cash flows provided by operating activities will continue to grow.

Expense Support Agreements

As discussed above, during the three months ended March 31, 2015, our cash from operating activities was positively impacted by the Expense Support Agreements, which we entered into with our Advisor and Property Manager commencing on April 1, 2013 and automatically renew for successive one-year periods thereafter, subject to the right of the Advisor or Property Manager to terminate their respective agreements upon 30 days’ written notice. Pursuant to the Expense Support Agreements, our Advisor and Property Manager have agreed to forgo the payment of fees in cash and accept restricted forfeitable stock for services in an amount equal to the positive excess, if any, of (a) aggregate stockholder cash distributions declared for the applicable quarter, over (b) our aggregate modified funds from operations (as defined in the Expense Support Agreements). The Advisor expense support amount is determined for each calendar quarter, on a non-cumulative basis, on each quarter-end date. The Property Manager expense support amount is determined for each calendar quarter, on a non-cumulative basis, after the calculation of the Advisor expense support amount pursuant to the Property Manager Expense Support Agreement on each quarter-end date. For the three months ended March 31, 2015 and 2014, our Advisor had settled approximately $0.5 million and $0.8 million, respectively, in asset management fees in accordance with the terms of the Advisor Expense Support Agreement. There were no amounts settled under the Property Manager expense support agreement through March 31, 2015.

In exchange for services rendered and in consideration of the expense support provided, the Company will issue, within 45 days following each Determination Date, a number of shares of restricted stock equal to the quotient of the expense support amount provided by to the Advisor and Property Manager for the preceding quarter divided by the then-current public offering price per share of common stock, on the terms and conditions and subject to the restrictions set forth in the Advisor Expense Support Agreement and the Property Manager Expense Support Agreement (hereinafter collectively referred to as the “Expense Support Agreements”). Any amounts deferred, and for which restricted stock shares are issued, pursuant to the Expense Support Agreements will be permanently waived and the Company will have no obligation to pay such amounts to the Advisor or the Property Manager. The Restricted Stock is subordinated and forfeited to the extent that shareholders do not receive their original invested capital back with at least a 6% annualized return of investment upon ultimate liquidity of the company

Refer to Note 11. “Related Party Arrangements” for additional information.

41


Uses of Liquidity and Capital Resources

Acquisitions

During the three months ended March 31, 2015 and 2014, we acquired three and ten consolidated operating properties for an aggregate purchase price paid of approximately $76.1 million and $186.8 million, respectively, net of liabilities assumed. The acquired operating properties were spread across our targeted asset classes and located in three and five different states, respectively, which allowed us to expand both the variety of our asset classes and the geographical diversification of our healthcare investment portfolio. In addition, the operating properties acquired during the three months ended March 31, 2015 increased our total units by 40. The operating properties acquired during the three months ended March 31, 2014 increased our total units by 771. Furthermore, during the three months ended March 31, 2015 and 2014, our total leasable square footage increased by approximately 0.2 million and 0.1 million, respectively. We expect to continue to expand our healthcare investment portfolio in the near term through additional acquisitions.

Development Properties

In connection with our various senior housing developments, we funded approximately $17.6 million and $12.2 million in development costs during the three months ended March 31, 2015 and 2014, respectively. Pursuant to the development agreements for the other active senior housing communities under development as of March 31, 2015, we expect to fund approximately $59.2 million of additional development and other costs. We expect to fund the remaining development and other costs primarily from construction loans on each development or with proceeds from our Offerings. Our Advisor continues to evaluate additional development opportunities.

Debt Repayments

During the three months ended March 31, 2015, we paid approximately $65.3 million of total repayments which is comprised of $31.4 million in repayments on our Revolving Credit Facility, $30.0 million in repayments on our mortgage loan for the Perennial Communities prior to its scheduled maturity and $3.9 million of scheduled repayments. During the three months ended March 31, 2014, we had total repayments of $1.9 million.

In April 2015, we made repayments on our mortgage loan for the Medical Portfolio I Properties of approximately $34.5 million as well as approximately $2.6 million of prepayments on our mortgage loan for the Capital Health Communities related to monies received under the Yield Guaranty.

Stock Issuance and Offering Costs

Under the terms of the Offerings, certain affiliates and third-party broker dealers are entitled to receive selling commissions of up to 7% of gross offering proceeds on all shares sold, a marketing support fee of up to 3% of gross offering proceeds, and reimbursement of actual expenses incurred in connection with the Offerings. In accordance with our articles of incorporation and the advisory agreement, the total amount of selling commissions, marketing support fees, due diligence expense reimbursements, and organizational and other offering costs to be paid by us may not exceed 15% of the gross aggregate proceeds of our Offerings.

During the three months ended March 31, 2015 and 2014, we paid approximately $19.4 million and $8.2 million, respectively, of stock issuance and offering costs.

42


Lease Incentives

During the three months ended March 31, 2015, we paid approximately $0.9 million of lease incentives in connection with the build-out of space for certain tenants at our medical office buildings. There were no lease incentives paid during the three months ended March 31, 2014. Lease incentives are capitalized as deferred rent and amortized over the respective lease terms.

In April 2015, we paid approximately $1.7 million of lease incentives in connection with the build-out of approximately 25,000 square feet of space for a new tenant at Physicians Plaza B at North Knoxville Medical Center. The related lease commenced in April 2015 upon completion of the build-out and includes an initial 10-year lease term that also provides the tenant with two 5-year renewal options .

In addition, in April 2015, we executed a lease modification with the tenant at Houston Orthopedic & Spine Hospital (“HOSH”), which included an extension of the lease term from 2023 to 2038 and provides the tenant with three 10-year renewal options. In connection therewith, the tenant agreed to extend the lease term of its current space in the HOSH MOB from 2023 to 2038 and lease approximately 7,000 square feet of additional space by the end 2015 that would be co-terminus with lease terms through 2038. We paid the tenant approximately $3.0 million of aggregate lease incentives in connection with the lease modifications and leasing of additional space.

While we expect the impact of these lease incentives to adversely impact our cash flows from operations in the near term, we anticipate that the new leasing activity will contribute to same-store NOI growth in future periods and that the extension of existing lease terms could increase the value of our properties.

Distributions

In order to qualify as a REIT, we are required to make distributions, other than capital gain distributions, to our stockholders each year in the amount of at least 90% of our taxable income. We may make distributions in the form of cash or other property, including distributions of our own securities. Until we have sufficient cash flow from operating activities or funds from operations, we have decided and may continue to make stock distributions or to fund all or a portion of the payment of distributions from other sources; such as from cash flows generated by financing activities, a component of which includes our borrowings and the proceeds of our Offerings.

In November 2014, in connection with our determination of the Company’s estimated NAV per share, we announced that our board of directors increased the amount of monthly cash distributions to $0.0353 per share (from $0.0338 per share) together with monthly stock distributions of 0.0025 shares of common stock payable to all common stockholders of record as of the close of business on the first business day of each month beginning December 1, 2014. This change allowed us to maintain our historical annual distribution rate of 4.0% in cash (based on our current $10.58 offering price) and 3% in stock (based on three shares for each 100 outstanding shares of our common stock). The new distribution rates were payable to all common stockholders of record as of the close of business of the first day of each month beginning December 1, 2014.

43


The following table represents total cash distributions declared, distributions reinvested and cash distributions per share for three months ended March 31, 2015 and 2014 (in thousands, except per share data):

Distributions Paid (1)

Periods

Cash
Distributions
per Share
Total Cash
Distributions
Declared
Reinvested via
Reinvestment
Plan
Cash
Distributions
net of
Reinvestment
Proceeds
Stock
Distributions
Declared
(Shares)
Stock
Distributions
Declared

(at then-
current
offering price)
Total Cash
and Stock
Distributions
Declared (2)
Cash Flows
Provided by
Operating
Activities (3)

2015 Quarters

First

$ 0.1059 $ 13,248 $ 7,648 $ 5,600 943 $ 9,977 $ 23,225 $ 11,317

Total

$ 0.1059 $ 13,248 $ 7,648 $ 5,600 943 $ 9,977 $ 23,225 $ 11,317

2014 Quarters

First

$ 0.1014 $ 6,147 $ 3,349 $ 2,798 455 $ 4,614 $ 10,761 $ 6,277

Total

$ 0.1014 $ 6,147 $ 3,349 $ 2,798 455 $ 4,614 $ 10,761 $ 6,277

FOOTNOTES:

(1) Represents the amount of cash used to fund distributions and the amount of distributions paid which were reinvested in additional shares through our Reinvestment Plan.
(2) For the three months ended March 31, 2015 and 2014, our net loss was approximately $18.0 million and $12.5 million, respectively, while cash distributions declared were approximately $13.2 million and $6.1 million, respectively, and total distributions declared were approximately $23.2 million, and $10.8 million, respectively. For the three months ended March 31, 2015 and 2014, approximately 85% and 100%, respectively, of cash distributions declared to stockholders were considered to be funded with cash provided by operating activities as calculated on a quarterly basis for GAAP purposes and approximately 15% and 0%, respectively, were considered to be funded with other sources (i.e., Offering proceeds). For the three months ended March 31, 2015 and 2014, approximately 49% and 58%, respectively, of total distributions declared to stockholders were considered to be funded with cash provided by operating activities as calculated on a quarterly basis for GAAP purposes and approximately 51% and 42%, respectively, of total distributions declared to stockholders were considered to be funded with other sources (i.e., Offering proceeds).
(3) Cash flows from operating activities calculated in accordance with GAAP are not necessarily indicative of the amount of cash available to pay distributions. For example, GAAP requires that the payment of acquisition fees and costs related to business combinations be classified as a use of cash in operating activities in the statement of cash flows, which directly reduces the measure of cash flows from operations. However, acquisition fees and costs are paid for with proceeds from our Offerings as opposed to operating cash flows. For the three months ended March 31, 2015 and 2014, we expensed approximately $2.3 million and $7.2 million, respectively, in acquisition fees and expenses, which were paid from the proceeds of our Offerings. Additionally, the board of directors also uses other measures such as FFO and MFFO in order to evaluate the level of distributions.

44


The tax composition of our distributions declared for the three months ended March 31, 2015 and 2014 were as follows:

March 31,

Distribution Type

2015 2014

Taxable as ordinary income

48.9 % 20.0 %

Return of capital

51.1 % 80.0 %

No amounts distributed to stockholders for the three months ended March 31, 2015 and 2014 were required to be or have been treated as return of capital for purposes of calculating the stockholders’ return on their invested capital as described in our advisory agreement.

Common Stock Redemptions

We have adopted a share redemption plan that allows our stockholders who hold shares for at least one year to request that we redeem between 25% and 100% of their shares. If we have sufficient funds available to do so and if we choose, in our sole discretion, to redeem shares, the number of shares we may redeem in any calendar year and the price at which they are redeemed are subject to conditions and limitations, including:

If we elect to redeem shares, some or all of the proceeds from the sale of shares under our distribution reinvestment plan attributable to any quarter may be used to redeem shares presented for redemption during such quarter. In addition, we may use the unused amount of any offering proceeds available for use in future quarters to the extent not used to invest in assets or for other purposes;

No more than 5% of the weighted average number of shares of our common stock outstanding during such 12-month period may be redeemed during such 12-month period; and

Redemption pricing shall not exceed an amount equal to the lesser of (i) the then-current public offering price for our shares of common stock (other than the price at which the shares are sold under our Reinvestment Plan); and (ii) the purchaser price paid by the stockholder.

Our board of directors has the ability, in its sole discretion, to amend or suspend the redemption plan or to waive any specific conditions if it is deemed to be in our best interest.

During the three months ended March 31, 2015, we paid approximately $0.9 million related to prior year redemption requests that were payable as of December 31, 2014 and received redemption requests for 0.2 million shares at a redemption price of $9.51 per share for which approximately $1.9 million was payable as of March 31, 2015. During the three months ended March 31, 2014, we received redemption requests for 0.03 million shares at a redemption price of $9.13 per share of which approximately $0.1 million was paid and approximately $0.2 million was payable as of March 31, 2014.

Results of Operations

The following discussion and analysis should be read in conjunction with the consolidated financial statements and the notes thereto of our Annual Report on Form 10-K for the year ended December 31, 2014.

As of March 31, 2015, we owned 98 real estate investment properties and our portfolio consisted of 4,958 units operated under management agreements with third-party operators under RIDEA structures and approximately 3.7 million leasable square feet that was 94.6% leased to third-party tenants.

In understanding our operating results in the accompanying consolidated financial statements, it is important to understand how the growth in our assets has impacted our results. In addition, we have aggregated NOI on a “same-store” basis only for comparable properties that we have owned during the entirety of all periods presented. Non-same-store NOI represents aggregated NOI from acquisitions made after January 1, 2014, which are excluded as we did not own those properties during the entirety of all periods presented.

45


The chart below illustrates our net losses, property-level NOI and same-store NOI for the three months ended March 31, 2015 and 2014 (in thousands), and the amount invested in properties as of March 31, 2015 and 2014 (in thousands):

Three Months Ended
March 31, Change
2015 2014 $ %

Net loss

$ (18,005 ) $ (12,523 )

Adjusted to exclude:

General and administrative expenses

2,019 1,757

Acquisition fees and expenses

2,330 7,205

Asset management fees

4,210 1,770

Impairment provision

5,524

Depreciation and amortization

23,293 11,862

Other expenses, net of other income

10,032 5,178

Income tax expense (benefit)

64 (30 )

NOI

29,467 15,219

Less: Non-same-store NOI

(14,953 ) (1,384 )

Same-store NOI

$ 14,514 $ 13,835 $ 679 4.9 %

Invested in operating properties, end of period

$ 1,941,995 $ 1,088,736

We anticipate using our cash on hand as of March 31, 2015, additional borrowings as well as additional net proceeds received through our Offerings to invest in additional properties. As such, we anticipate additional operating income will be generated in subsequent periods.

We are not aware of any material trends or uncertainties, favorable or unfavorable, that may be reasonably anticipated to have a material impact on either capital resources or the revenues or income to be derived from the acquisition and operation of properties, loans and other permitted investments, other than those referred to in the risk factors identified in “Part II, Item 1A” of this report and the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2014.

Three Months Ended March 31, 2015 as compared to the three months ended March 31, 2014

Rental Income from Operating Leases. Rental income from operating leases was approximately $21.6 million and $9.7 million, respectively, for the three months ended March 31, 2015 and 2014. The increase in rental income from operating leases resulted from our acquisition of 17 medical office buildings, three post-acute care hospitals and three acute care hospitals subsequent to March 31, 2014 as well as the one medical office building during the three months ended March 31, 2014 being owned for the entire period. We expect this revenue stream to increase as these investments are held in future periods and we acquire additional properties with operating leases.

Resident Fees and Services. Resident fees and services income was approximately $40.0 million and $22.0 million, respectively, for the three months ended March 31, 2015 and 2014. The increase in resident fees and services is a result of the six managed senior housing communities acquired subsequent to March 31, 2014, nine managed senior housing communities acquired during the three months ended March 31, 2014 being owned for the entire period as well as Dogwood Forest of Acworth being placed into service in June 2014 and same-store growth from HarborChase of Villages Crossing that was placed into service in December 2013. We expect this revenue stream to increase as these investments are held in future periods, our value-add and completed development properties stabilize and we acquire additional managed senior housing communities.

Tenant Reimbursement Income. Tenant reimbursement income was approximately $3.4 million and $1.5 million, respectively, for the three months ended March 31, 2015 and 2014. This amount is comprised of common area maintenance (“CAM”) revenue and the increase resulted from our acquisition of 17 medical office buildings, three post-acute care hospitals and three acute care hospitals subsequent to March 31, 2014 as well as the one medical office building during the three months ended March 31, 2014 being owned for the entire period. We expect this revenue stream to increase as these investments are held in future periods and we acquire additional properties with modified operating leases.

46


Interest Income on Note Receivable from Related Party. Interest income on note receivable from related party was approximately $0.1 million for the three months ended March 31, 2014. This amount is comprised of interest income on the outstanding ADC loan made to Crosland Southeast for the HCA Rutland development beginning in June 2013. Interest income from this loan ceased once the ADC loan was repaid in August 2014.

Property Operating Expenses. Property operating expenses were approximately $32.3 million and $16.4 million, respectively, for the three months ended March 31, 2015 and 2014. This increase is a result of our acquisition of six managed senior housing communities, 17 medical office buildings, three post-acute care hospitals and three acute care hospitals subsequent to March 31, 2014 as well as nine managed senior housing communities and one medical office building acquired during the three months ended March 31, 2014 being owned for the entire period. In addition, Dogwood Forest of Acworth and HarborChase of Villages Crossing were placed into service in June 2014 and December 2013, respectively, which further contributed to the increase as operations continued to ramp-up across periods. We expect property operating expenses to increase as these investments are held in future periods, our value-add and completed development properties stabilize and we acquire additional managed properties.

General and Administrative. General and administrative expenses for three months ended March 31, 2015 and 2014 were approximately $2.0 million and $1.8 million, respectively. General and administrative expenses were comprised primarily of personnel expenses of affiliates of our Advisor, directors’ and officers’ insurance, franchise taxes, accounting and legal fees, and board of director fees and will continue to grow as our asset base increases. The increase in general and administrative expense was primarily attributed to increased costs as a result of the growth of our portfolio. Specifically, we incurred increased personnel expenses reimbursable to the Advisor due to increased accounting, legal and administrative activity as a result of the growth of the portfolio and related reporting. We expect increases in general and administrative expenses in the future as we purchase additional real estate properties and the properties acquired during the three months ended March 31, 2015 are operational for a full period.

Acquisition Fees and Expenses. Acquisition fees and expenses for three months ended March 31, 2015 and 2014 were approximately $2.3 million and $8.4 million, respectively. For the three months ended March 31, 2014 approximately $1.2 million was capitalized as real estate under development. No acquisition fees and expenses were capitalized for the three months ended March 31, 2015. The decrease in acquisition fees and expenses is a result of having acquired three operating properties totaling approximately $76.6 million during the three months ended March 31, 2015 as compared with the acquisition of ten operating properties totaling approximately $190.6 million during the three months ended March 31, 2014. We expect to incur additional acquisition fees and expenses in the future as we purchase additional real estate or real estate-related assets.

Asset Management Fees . We incurred approximately $4.9 million and $2.7 million in asset management fees payable to our Advisor during three months ended March 31, 2015 and 2014, respectively. For three months ended March 31, 2015 and 2014, approximately $0.5 million and $0.8 million, respectively, in asset management fees were settled in accordance with the terms of the Expense Support Agreements and approximately $0.1 million was capitalized as real estate under development for each period. As described in Note 11. “Related Party Arrangements,” during three months ended March 31, 2015, asset management fees were reduced by $0.5 million, because the shares of restricted stock, which will be accepted by the Advisor as payment for asset management services rendered, were valued at zero— the lowest possible value estimated at vesting since the vesting criteria had not been met. For the three months ended March 31, 2014, approximately $0.8 million in asset management fees were settled with issuance of restricted stock in accordance with the Expense Support Agreements. Monthly asset management fees equal to 0.08334% of invested assets are paid to the Advisor for management of our real estate assets, including our pro rata share of our investments in unconsolidated entities, loans and other permitted investments. We expect increases in asset management fees in the future as we purchase additional real estate or real estate-related assets and the properties owned as of March 31, 2015 are operational for a full period; however, a portion of such fees may be settled in the form of forfeitable restricted stock under the Expense Support Agreements.

47


Property Management Fees . We incurred approximately $4.1 million and $1.7 million in property and construction management fees for three months ended March 31, 2015 and 2014, respectively. For three months ended March 31, 2015 and 2014, approximately $0.8 million and $0.1 million, respectively, was capitalized as real estate under development. Property management fees generally range from 2% to 5% of property revenues for leased properties depending on the type of property and are paid to third-party managers. However, an oversight fee equal to 1% of property revenues is paid to the Property Manager for those properties managed by a third-party. Overall property management fees increased as a result of the increases in rental income from operating leases and resident fees and services from acquisitions subsequent to March 31, 2014 as well as the properties acquired during the three months ended March 31, 2014 being owned for the entire three months ended March 31, 2015. Although we expect total property management fees will increase during 2015, a portion of such fees may be settled in the form of forfeitable restricted stock under the Expense Support Agreements.

Impairment Provision. During the three months ended March 31, 2015, we recorded an impairment provision to write-off the lease intangibles and deferred rent assets related to two of our specialty hospitals, as it was determined that the carrying value of these assets would not be recoverable; refer to Note 5. “Intangibles, net” for additional information. There were no impairments during the three months ended March 31, 2014.

Depreciation and Amortization. Depreciation and amortization expenses for three months ended March 31, 2015 and 2014 were approximately $23.3 million and $11.9 million, respectively. Depreciation and amortization expenses are comprised of depreciation and amortization of the buildings, equipment, land improvements and in-place leases related to our real estate portfolio. The increase in depreciation and amortization expense across periods resulted from our acquisition of six managed senior housing communities, 17 medical office buildings, three post-acute care hospitals and three acute care hospitals subsequent to March 31, 2014 as well as nine managed senior housing communities and one medical office building acquired during the three months ended March 31, 2014 being owned for the entire period and Dogwood Forest of Acworth being placed into service in June 2014. We expect depreciation and amortization expense to increase as these investments are held in future periods and we acquire additional properties.

Interest Expense and Loan Cost Amortization . Interest expense and loan cost amortization for three months ended March 31, 2015 and 2014 were approximately $10.4 million and $5.8 million, respectively, of which $0.5 million and $0.3 million, respectively, was capitalized as development costs relating to our real estate under development. Approximately $3.9 million of the increase for three months ended March 31, 2015 was primarily the result of an increase in our average debt outstanding to approximately $1.0 billion, as compared with approximately $597.3 million for three months ended March 31, 2015 and 2014, respectively. In addition, during three months ended March 31, 2015, we incurred approximately $0.2 million in additional loan cost amortization relating to debt obtained subsequent to March 31, 2014, as well as approximately $0.03 million relating to debt obtained on properties acquired during the three months ended March 31, 2014. Moreover, during the three months ended March 31, 2015, we recorded a write-off of approximately $0.2 million in loan costs and paid approximately $0.1 million on the derecognition of a cash flow hedge in connection with the early extinguishment of debt.

Equity in Earnings (Loss) of Unconsolidated Entities . Our unconsolidated entities generated losses of approximately ($0.2) million for three months ended March 31, 2015 relating to our investment in the Windsor Manor joint venture, as compared to earnings of approximately $0.3 million for three months ended March 31, 2014 relating to our investments in the Windsor Manor and Montecito joint ventures. The change across periods is primarily reflective of purchasing the controlling interest in the Montecito Joint Venture in August 2014, which resulted in consolidation of the investment.

Income Tax (Expense) Benefit. During three months ended March 31, 2015 and 2014, we recognized state and federal income tax (expense) benefit related to our properties of approximately ($0.06) million and $0.03 million, respectively.

48


Funds from Operations and Modified Funds from Operations

Due to certain unique operating characteristics of real estate companies, as discussed below, National Association Real Estate Investment Trust (“NAREIT”) promulgated a measure known as funds from operations (“FFO”), which we believe to be an appropriate supplemental measure to reflect the operating performance of a REIT. The use of FFO is recommended by the REIT industry as a supplemental performance measure. FFO is not equivalent to net income or loss as determined under GAAP.

We define FFO, a non-GAAP measure, consistent with the standards approved by the Board of Governors of NAREIT. NAREIT defines FFO as net income or loss computed in accordance with GAAP, excluding gains or losses from sales of property, real estate asset impairment write-downs, plus depreciation and amortization of real estate related assets, and after adjustments for unconsolidated partnerships and joint ventures. Our FFO calculation complies with NAREIT’s policy described above.

The historical accounting convention used for real estate assets requires straight-line depreciation of buildings and improvements, which implies that the value of real estate assets diminishes predictably over time, especially if such assets are not adequately maintained or repaired and renovated as required by relevant circumstances and/or is requested or required by lessees for operational purposes in order to maintain the value of the property. We believe that, because real estate values historically rise and fall with market conditions, including inflation, interest rates, the business cycle, unemployment and consumer spending, presentations of operating results for a REIT using historical accounting for depreciation may be less informative. Historical accounting for real estate involves the use of GAAP. Any other method of accounting for real estate such as the fair value method cannot be construed to be any more accurate or relevant than the comparable methodologies of real estate valuation found in GAAP. Nevertheless, we believe that the use of FFO, which excludes the impact of real estate related depreciation and amortization, provides a more complete understanding of our performance to investors and to management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses, and interest costs, which may not be immediately apparent from net income or loss. However, FFO and modified funds from operations (“MFFO”), as described below, should not be construed to be more relevant or accurate than the current GAAP methodology in calculating net income or loss in its applicability in evaluating operating performance. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP FFO and MFFO measures and the adjustments to GAAP in calculating FFO and MFFO.

Changes in the accounting and reporting promulgations under GAAP (for acquisition fees and expenses for business combinations from a capitalization/depreciation model) to an expensed-as-incurred model that were put into effect in 2009 and other changes to GAAP accounting for real estate subsequent to the establishment of NAREIT’s definition of FFO have prompted an increase in cash-settled expenses, specifically acquisition fees and expenses, as items that are expensed under GAAP and accounted for as operating expenses. Our management believes these fees and expenses do not affect our overall long-term operating performance. Publicly registered, non-listed REITs typically have a significant amount of acquisition activity and are substantially more dynamic during their initial years of investment and operation. While other start up entities may also experience significant acquisition activity during their initial years, we believe that non-listed REITs are unique in that they have a limited life with targeted exit strategies within a relatively limited time frame after its acquisition activity ceases. Due to the above factors and other unique features of publicly registered, non-listed REITs, the Investment Program Association (“IPA”), an industry trade group, has standardized a measure known as MFFO which the IPA has recommended as a supplemental measure for publicly registered non-listed REITs and which we believe to be another appropriate supplemental measure to reflect the operating performance of a non-listed REIT. MFFO is not equivalent to our net income or loss as determined under GAAP, and MFFO may not be a useful measure of the impact of long-term operating performance on value if we do not continue to operate with a limited life and targeted exit strategy, as currently intended. We believe that because MFFO excludes costs that we consider more reflective of investing activities and other non-operating items included in FFO and also excludes acquisition fees and expenses that affect our operations only in periods in which properties are acquired, MFFO can provide, on a going forward basis, an indication of the sustainability (that is, the capacity to continue to be maintained) of our operating performance after the period in which we acquired our properties and once our portfolio is in place. By providing MFFO, we believe we are presenting useful information that assists investors and analysts to better assess the sustainability of our operating performance after our properties have been acquired. We also believe that MFFO is a recognized measure of sustainable operating performance by the non-listed REIT industry.

49


We define MFFO, a non-GAAP measure, consistent with the IPA’s Guideline 2010-01, Supplemental Performance Measure for Publicly Registered, Non-Listed REITs: MFFO, or the Practice Guideline, issued by the IPA in November 2010. The Practice Guideline defines MFFO as FFO further adjusted for the following items, as applicable, included in the determination of GAAP net income or loss: acquisition fees and expenses; amounts relating to deferred rent receivables and amortization of above and below market leases and liabilities (which are adjusted in order to remove the impact of GAAP straight-line adjustments from rental revenues); accretion of discounts and amortization of premiums on debt investments, mark-to-market adjustments included in net income; nonrecurring gains or losses included in net income from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan, and unrealized gains or losses resulting from consolidation from, or deconsolidation to, equity accounting and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect MFFO on the same basis. The accretion of discounts and amortization of premiums on debt investments, nonrecurring unrealized gains and losses on hedges, foreign exchange, derivatives or securities holdings, unrealized gains and losses resulting from consolidations, as well as other listed cash flow adjustments are adjustments made to net income in calculating the cash flows provided by operating activities and, in some cases, reflect gains or losses which are unrealized and may not ultimately be realized.

Our MFFO calculation complies with the IPA’s Practice Guideline described above. In calculating MFFO, we exclude acquisition related expenses. Under GAAP, acquisition fees and expenses are characterized as operating expenses in determining operating net income or loss. These expenses are paid in cash by us. All paid and accrued acquisition fees and expenses will have negative effects on returns to investors, the potential for future distributions, and cash flows generated by us, unless earnings from operations or net sales proceeds from the disposition of other properties are generated to cover the purchase price of the property.

Our management uses MFFO and the adjustments used to calculate it in order to evaluate our performance against other non-listed REITs which have limited lives with short and defined acquisition periods and targeted exit strategies shortly thereafter. As noted above, MFFO may not be a useful measure of the impact of long-term operating performance on value if we do not continue to operate in this manner. We believe that our use of MFFO and the adjustments used to calculate it allow us to present our performance in a manner that reflects certain characteristics that are unique to non-listed REITs, such as their limited life, limited and defined acquisition period and targeted exit strategy, and hence that the use of such measures is useful to investors. For example, acquisition costs are funded from our subscription proceeds and other financing sources and not from operations. By excluding expensed acquisition costs, the use of MFFO provides information consistent with management’s analysis of the operating performance of the properties.

Presentation of this information is intended to provide useful information to investors as they compare the operating performance of different non-listed REITs, although it should be noted that not all REITs calculate FFO and MFFO the same way and as such comparisons with other REITs may not be meaningful. Furthermore, FFO and MFFO are not necessarily indicative of cash flows available to fund cash needs and should not be considered as an alternative to net income (loss) or income (loss) from continuing operations as an indication of our performance, as an alternative to cash flows from operations as an indication of our liquidity, or indicative of funds available to fund our cash needs including our ability to make distributions to our stockholders. FFO and MFFO should be reviewed in conjunction with other GAAP measurements as an indication of our performance. Now that our NAV is disclosed and updated at least annually, MFFO is useful in assisting management and investors in assessing the sustainability of operating performance in future operating periods, and in particular, after the offering and acquisition stages are complete. FFO and MFFO are not useful measures in evaluating net asset value because impairments are taken into account in determining net asset value but not in determining FFO and MFFO.

50


Neither the SEC, NAREIT nor any other regulatory body has passed judgment on the acceptability of the adjustments we use to calculate FFO or MFFO. In the future, the SEC, NAREIT or another regulatory body may decide to standardize the allowable adjustments across the non-listed REIT industry and we would have to adjust its calculation and characterization of FFO or MFFO.

The following table presents a reconciliation of net loss to FFO and MFFO for the three months ended March 31, 2015 and 2014 (in thousands, except per share data):

Three Months Ended March 31,
2015 2014

Net loss attributable to common stockholders

$ (18,000 ) $ (12,523 )

Adjustments:

Depreciation and amortization

23,293 11,862

Impairment provision on real estate assets

4,661

FFO adjustments from unconsolidated entities (1)

620 161

Total funds from operations

10,574 (500 )

Acquisition fees and expenses (2)

2,330 7,205

Straight-line adjustments for leases (3)

(917 ) (621 )

Amortization of above/below market intangible assets and liabilities (4)

145 53

Loss on extinguishment of debt (5)

308

Impairment provision on lease related costs (6)

863

MFFO adjustments from unconsolidated entities (1)

14

Modified funds from operations

$ 13,303 $ 6,151

Weighted average number of shares of common stock outstanding (basic and diluted) (7)

129,627 62,429

Net loss per share (basic and diluted)

$ (0.14 ) $ (0.20 )

FFO per share (basic and diluted)

$ 0.08 $ (0.01 )

MFFO per share (basic and diluted)

$ 0.10 $ 0.10

FOOTNOTES:

(1) This amount represents our share of the FFO or MFFO adjustments allowable under the NAREIT or IPA definitions, respectively, calculated using the HLBV method.
(2) In evaluating investments in real estate, management differentiates the costs to acquire the investment from the operations derived from the investment. By adding back acquisition expenses, management believes MFFO provides useful supplemental information of its operating performance and will also allow comparability between different real estate entities regardless of their level of acquisition activities. Acquisition expenses include payments to our Advisor or third parties. Acquisition expenses for business combinations under GAAP are considered operating expenses and as expenses included in the determination of net income (loss) and income (loss) from continuing operations, both of which are performance measures under GAAP. All paid or accrued acquisition expenses will have negative effects on returns to investors, the potential for future distributions, and cash flows generated by us, unless earnings from operations or net sales proceeds from the disposition of properties are generated to cover the purchase price of the property.
(3) Under GAAP, rental receipts are allocated to periods using various methodologies. This may result in income recognition that is significantly different than underlying contract terms. By adjusting for these items (to reflect such payments from a GAAP accrual basis to a cash basis of disclosing the rent and lease payments), MFFO provides useful supplemental information on the realized economic impact of lease terms and debt investments, providing insight on the contractual cash flows of such lease terms and debt investments, and aligns results with management’s analysis of operating performance.

51


(4) Under GAAP, certain intangibles are accounted for at cost and reviewed at least annually for impairment, and certain intangibles are assumed to diminish predictably in value over time and are amortized, similar to depreciation and amortization of other real estate-related assets that are excluded from FFO. However, because real estate values and market lease rates historically rise or fall with market conditions, management believes that by excluding charges relating to amortization of these intangibles, MFFO provides useful supplemental information on the performance of the real estate.
(5) Management believes that adjusting for the realized loss on the early extinguishment of debt is appropriate because the write-off of unamortized loan costs is a non-recurring, non-cash adjustment that is not reflective of our ongoing operating performance and aligns results with management’s analysis of operating performance.
(6) Management believes that adjusting for impairment provisions on lease related assets is appropriate because they are non-recurring, non-cash adjustments that is not reflective of our ongoing operating performance and aligns results with management’s analysis of operating performance.
(7) For purposes of determining the weighted average number of shares of common stock outstanding, stock distributions are treated as if they were outstanding as of the beginning of the periods presented.

Off-Balance Sheet Arrangements

See our Annual Report on Form 10-K for the year ended December 31, 2014 for a summary of our off-balance sheet arrangements.

Contractual Obligations

The following table presents our contractual obligations and the related payment periods as of March 31, 2015:

Payments Due by Period
2015 2016-2017 2018-2019 Thereafter Total

Mortgage and other notes payable (principal and interest)

$ 35,750 $ 165,827 $ 613,454 $ 155,121 $ 970,152

Credit Facilities (principal and interest)

3,907 7,814 179,558 191,279

Development contracts on development properties (1)

51,911 7,243 59,154

Ground and air rights leases (2)

1,231 3,371 3,529 120,533 128,664

$ 92,799 $ 184,255 $ 796,541 $ 275,654 $ 1,349,249

FOOTNOTES:

(1) The amounts presented above represent accrued development costs as of March 31, 2015 and development costs not yet incurred of the aggregate budgeted development costs, including start-up costs, in accordance with the development agreements, and the expected timing of such costs. The amounts include approximately $54.6 million of contractual obligations with third-party developers and approximately $4.6 million of additional expected development costs that have been included in the respective development budgets.
(2) Ground and air rights leases are operating leases with scheduled payments over the life of the respective leases and with expirations ranging from 2053 to 2101.

Critical Accounting Policies and Estimates

See Item 1. “Financial Statements” and our Annual Report on Form 10-K for the year ended December 31, 2014 for a summary of our critical accounting policies and estimates.

Recent Accounting Pronouncements

See Item 1. “Financial Information” for a summary of the impact of recent accounting pronouncements.

52


Item 3. Quantitative and Qualitative Disclosures about Market Risks

We may be exposed to interest rate changes primarily as a result of long-term debt used to acquire properties and to make loans and other permitted investments. Our management objectives related to interest rate risk will be to limit the impact of interest rate changes on earnings and cash flows and to lower our overall borrowing costs. To achieve our objectives, we expect to borrow primarily at fixed rates or variable rates with the lowest margins available, and in some cases, with the ability to convert variable rates to fixed rates. With regard to variable rate financing, we will assess interest rate cash flow risk by continually identifying and monitoring changes in interest rate exposures that may adversely impact expected future cash flows and by evaluating hedging opportunities.

The following is a schedule as of March 31, 2015, of our fixed and variable rate debt maturities for the remainder of 2015, and each of the next four years and thereafter (principal maturities only) (in thousands):

Expected Maturities
2015 2016 2017 2018 2019 Thereafter Total Fair Value (1)

Fixed rate debt

$ 6,682 $ 9,257 $ 9,671 $ 203,621 $ 4,309 $ 142,689 $ 376,229 $ 391,000

Weighted average interest rate on fixed debt

4.25 % 4.25 % 4.25 % 4.30 % 4.19 % 4.19 % 4.25 %

Variable rate debt

$ 6,884 $ 60,928 $ 27,753 $ 93,671 $ 447,382 $ 636,618 $ 649,000

FOOTNOTE:

(1) The estimated fair value of our fixed and variable rate debt was determined using discounted cash flows based on market interest rates as of March 31, 2015. We determined market rates through discussions with our existing lenders pricing our loans with similar terms and current rates and spreads.

Management estimates that a one-percentage point increase or decrease in LIBOR in 2015 compared to LIBOR rates as of March 31, 2015 would result in fluctuation of interest expense on our variable rate debt of approximately $6.4 million for the year ending December 31, 2015. This sensitivity analysis contains certain simplifying assumptions, and although it gives an indication of our exposure to changes in interest rates, it is not intended to predict future results and actual results will likely vary given that our sensitivity analysis on the effects of changes in LIBOR does not factor in a potential change in variable rate debt levels, any offsetting gains on interest rate swap contracts, or the impact of any LIBOR floors or caps.

As of March 31, 2015, the Company’s debt is comprised of approximately 37.1% in fixed rate debt, approximately 56.3% in variable rate debt with current or forward-starting interest rate swaps and approximately 6.6% of unhedged variable rate debt. The remaining unhedged variable rate debt primarily relates to our construction loans. Overall, we believe longer term fixed rate debt could be beneficial in a rising interest rate or rising inflation rate environment and as such we continue to evaluate the need for additional interest rate swaps on unhedged variable rate debt.

53


Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our management, including our principal executive officer and principal financial officer concluded that our disclosure controls and procedures are effective at the reasonable assurance level as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

During the most recent fiscal quarter, there were no changes in our internal controls over financial reporting (as defined under Rule 13a-15(f) under the Exchange Act) that have materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings - None

Item 1A. Risk Factors

There have been no material changes in our assessment of our risk factors from those set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

During the period covered by this quarterly report, we did not sell any equity securities that were not registered under the Securities Act of 1933, and we did not repurchase any of our securities.

Secondary Sales of Registered Shares between Investors

We are not aware of any other transfers of shares by investors for the three months ended March 31, 2015 and we are not aware of any other trades of our shares, other than previous purchases made in our public offerings and redemptions of shares by us.

54


Issuer Purchases of Equity Securities

The following table presents details regarding our repurchase of securities between January 1, 2015 and March 31, 2015:

Period

Total
number

of shares
purchased
Average
price paid
per share
Total number
of shares
purchased as
part of a
publically
announced plan
Maximum
number of shares
that may yet be
purchased under
the plan
(1)

January 1, 2015 through January 31, 2015

2,839,123

February 1, 2015 through February 28, 2015

2,906,972

March 1, 2015 through March 31, 2015

204,184 $ 9.51 204,184 2,763,492

Total

204,184 $ 9.51 204,184

FOOTNOTES:

(1) This represents the maximum number of shares which can be redeemed under the redemption plan is subject to a five percent limitation in a rolling 12-month period as described above. However, we are not obligated to redeem such amounts and this does not take into account the amount the board of directors has determined to redeem or whether there are sufficient proceeds under the redemption plan. Under the redemption plan, we can, at our discretion, use the full amount of the proceeds from the sale of shares under our Reinvestment Plan attributable to any month to redeem shares presented for redemption during such month. Any amount of proceeds from our Offerings which is available for redemptions but which is unused may be carried over to the next succeeding calendar quarter for use in addition to the amount of proceeds from our Offerings and Reinvestment Plan proceeds that would otherwise be available for redemptions.

55


Use of Proceeds from Registered Securities

On June 27, 2011, our Registration Statement (File No. 333-168129 was declared effective by the SEC and our Initial Offering commenced and continued through the effectiveness of our Follow-on Offering on February 2, 2015. The use of proceeds from our Initial Offering was as follows as of March 31, 2015 (in thousands, except shares):

Total Payments to
Affiliates
(2)
Payments to
Others

Shares registered

300,000,000

Aggregate price of offering amount registered

$ 3,000,000

Shares sold (1)

128,663,652

Aggregate amount sold (3)

$ 1,271,440

Offering expenses (4)

(144,854 ) $ (87,759 ) $ (57,095 )

Net offering proceeds to the issuer

1,126,586

Proceeds from borrowings, net of loan costs

1,180,200

Total net offering proceeds and borrowings

2,306,786

Purchases of real estate and development costs

(1,924,547 ) (1,924,547 )

Repayment of borrowings

(205,113 ) (205,113 )

Payment of acquisition fees and expenses

(61,904 ) (40,535 ) (21,369 )

Investments in unconsolidated entities

(9,509 ) (9,509 )

Payment of distributions

(4,209 ) (19 ) (4,190 )

Redemption of common stock

(3,348 ) (3,347 )

Distribution to holder of promoted interest

(2,000 ) (2,000 )

Operating expenses (5)

(1,801 ) (1,466 ) (335 )

Deposits on real estate

(750 ) (750 )

Payment of leasing costs

(559 ) (559 )

Payment of lender deposits

(150 ) (150 )

Unused proceeds from Offering and borrowings (6)

$ 92,896

FOOTNOTES:

(1) Excludes 22,222 unregistered shares of our common stock sold to the Advisor in June 2010 and approximately 4.6 million shares issued as stock distributions as of March 31, 2015.
(2) Represents direct or indirect payments to directors, officers, or general partners of the issuer or their associates; to persons owning 10% or more of any class of equity securities of the issuer; and to affiliates of the issuer.
(3) Excludes dividend reinvestment proceeds of approximately $34.7 million.
(4) Offering expenses paid to affiliates includes selling commissions and marketing support fees paid to the Managing Dealer of our Offerings (all or a portion of which may be paid to unaffiliated participating brokers by the Managing Dealer). Reimbursements to our Advisor of expenses of the Offerings that it has incurred on our behalf from unrelated parties such as legal fees, auditing fees, printing costs, and registration fees are included in payments to others for purposes of this table.
(5) Until such time as we have sufficient operating cash flows from our assets, we will pay distributions, debt service and/or operating expenses from net proceeds of our Offerings and borrowings. The amounts presented above represent the net proceeds used for such purposes as of March 31, 2015.
(6) Unused proceeds from our Initial Offering of $92.9 million represent unused proceeds on hand as of March 31, 2015 and unused proceeds from our Follow-on Offering, which began in February 2015, represent approximately $23.5 million of cash on hand as of March 31, 2015.

We intend to pay offering expenses, acquire properties and make other permitted investments with proceeds from the Initial Offering. In addition, we have paid, and until such time as we have sufficient operating cash flows from our assets, we will continue to pay distributions and operating expenses from our net proceeds from our Offerings.

56


Item 3. Defaults Upon Senior Securities - None

Item 4. Mine Safety Disclosure - Not Applicable

Item 5. Other Information - None

Item 6. Exhibits

The exhibits required by this item are set forth in the Exhibit Index attached hereto and are filed or incorporated as part of this report.

57


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on the 13th day of May 2015.

CNL HEALTHCARE PROPERTIES, INC.
By:

/s/ Stephen H. Mauldin

STEPHEN H. MAULDIN
Chief Executive Officer
(Principal Executive Officer)
By:

/s/ Kevin R. Maddron

KEVIN R. MADDRON
Senior Vice President, Chief Financial Officer and Treasurer
(Principal Financial Officer)

58


EXHIBIT INDEX

Exhibit
No.
Description
31.1 Certification of Chief Executive Officer of CNL Healthcare Properties, Inc., Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
31.2 Certification of Chief Financial Officer of CNL Healthcare Properties, Inc., Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
32.1 Certification of Chief Executive Officer and Chief Financial Officer of CNL Healthcare Properties, Inc., Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
101 The following materials from CNL Healthcare Properties, Inc. Quarterly Report on Form 10-Q for the three months ended March 31, 2015, formatted in XBRL (Extensible Business Reporting Language); (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statement of Operations, (iii) Condensed Consolidated Statement of Comprehensive Loss, (iv) Condensed Consolidated Statements of Stockholders’ Equity and Redeemable Noncontrolling Interest, (v) Condensed Consolidated Statement of Cash Flows, and (vi) Notes to the Condensed Consolidated Financial Statements.

59

TABLE OF CONTENTS